[
    {
        "src_smiles": "Cn1c(SCC(=O)Nc2ccccc2)nc2ccccc2c1=O",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule Cn1c(SCC(=O)Nc2ccccc2)nc2ccccc2c1=O features a pyridine core substituted with a sulfanyl-carbonyl-amine-phenyl moiety. It contains two phenyl rings and a central carbonyl group, which are essential for interacting with the JNK3 enzyme's active site.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), a kinase involved in regulating apoptosis, inflammation, and neuronal functions. Effective JNK3 inhibitors can be valuable for therapeutic applications in diseases like neurodegeneration and cancer.",
            "Limitation in Source Molecule for Property": "The source molecule may have moderate selectivity and potency towards JNK3. Potential issues include suboptimal binding affinity, limited selectivity over other kinases, and possible poor pharmacokinetic properties such as solubility and metabolic stability.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, structural modifications can be made to increase binding affinity and selectivity. Introducing electron-donating or withdrawing groups on the phenyl rings could improve interactions within the kinase's active site. Modifying the sulfanyl-carbonyl linkage to enhance metabolic stability and solubility may also improve pharmacokinetic properties. Additionally, exploring bioisosteric replacements for functional groups could lead to increased selectivity against JNK3.",
            "Final Target Molecule": "Cn1c(SC(C)(=O)Nc2cc(C)ccc2)nc2ccccc2c1=O"
        }
    },
    {
        "src_smiles": "NC(=O)c1cncnc1Nc1cccc(C(F)(F)F)c1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, NC(=O)c1cncnc1Nc1cccc(C(F)(F)F)c1, consists of a carbamate linker attached to a 1,3,4-oxadiazole ring, which is further connected to a perfluorinated aniline derivative. The presence of the perfluoroaryl group may enhance binding affinity through hydrophobic interactions and metabolic stability.",
            "Property Analysis": "The molecule is designed to inhibit c-Jun N-terminal kinase 3 (JNK3), a kinase implicated in various neurological disorders. The carbamate and oxadiazole moieties may contribute to binding specificity and potency against JNK3.",
            "Limitation in Source Molecule for Property": "The source molecule may exhibit suboptimal selectivity towards JNK3 over other kinases, and the perfluorinated group might negatively affect the molecule's pharmacokinetic properties, such as solubility and bioavailability.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modify the perfluoroaryl group to improve selectivity and reduce lipophilicity, such as replacing the C(F)(F)F group with a less fluorinated substituent. Additionally, adjust the carbamate linker to better fit the JNK3 active site, potentially by introducing electron-donating or electron-withdrawing groups to optimize binding interactions. Incorporating a methyl or halogen substituent on the oxadiazole ring may also enhance binding affinity.",
            "Final Target Molecule": "NC(=O)c1cncnc1Nc1ccc(cc1)C(F)F"
        }
    },
    {
        "src_smiles": "COc1ncc2nc(-c3ccc(F)cc3)c(=O)n(C)c2n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a methoxy-substituted pyrimidine core fused with a diazepine ring. It features a fluorophenyl group attached to a nitrogen atom and a methyl group linked to another nitrogen. The molecule contains two carbonyl groups that may facilitate hydrogen bonding interactions with the target protein.",
            "Property Analysis": "The compound exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), likely through interactions involving the pyrimidine core and fluorophenyl substituents. The electron-donating methoxy group and electron-withdrawing fluorine atoms may enhance binding affinity and selectivity towards JNK3.",
            "Limitation in Source Molecule for Property": "Potential limitations include suboptimal selectivity over other kinases, limited potency against JNK3, and unfavorable pharmacokinetic properties such as poor solubility or metabolic stability. The N-methyl group may restrict hydrogen bonding opportunities necessary for stronger binding interactions with JNK3.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, consider replacing the N-methyl group with a hydrogen to allow additional hydrogen bonding. Modify the fluorophenyl substituent to improve selectivity and potency. Adjust the methoxy group to optimize solubility and reduce metabolic liabilities. Explore adding or modifying substituents on the pyrimidine core to increase binding affinity and selectivity based on structure-activity relationship (SAR) studies.",
            "Final Target Molecule": "COc1ncc2nc(-c3ccc(F)cc3)c(=O)n2n1"
        }
    },
    {
        "src_smiles": "c1cc(Nc2ccon2)nc(Nc2ccc(N3CCOCC3)cc2)n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a triazine core (1,3,5-triazine ring) substituted with three amine groups. One substituent contains a thiazolone moiety, another has a benzyl group linked to an ethoxyethyl side chain, and the third amine is directly attached to the triazine ring.",
            "Property Analysis": "JNK3 inhibition is influenced by the molecule's ability to form hydrogen bonds, hydrophobic interactions, and fit within the kinase's active site. Key features include the presence of hydrogen bond donors and acceptors, appropriate lipophilicity, and structural complementarity to the JNK3 binding pocket.",
            "Limitation in Source Molecule for Property": "The source molecule may exhibit suboptimal binding affinity due to limited hydrophobic interactions and potential steric hindrance from bulky substituents, which can reduce its selectivity and potency as a JNK3 inhibitor.",
            "Optimization for Source Molecule": "Introduce additional hydrophobic groups to enhance binding within the JNK3 active site, reduce steric bulk by modifying or replacing bulky substituents, and optimize hydrogen bond donors/acceptors to improve affinity and selectivity. Specifically, replacing the ethoxyethyl side chain with a more linear alkyl group and modifying the thiazolone moiety to increase planarity could enhance interactions with JNK3.",
            "Final Target Molecule": "c1cc(NC2=CC=O)nc(NC2=CC(C)C=C2)nc1N3CCOCC3"
        }
    },
    {
        "src_smiles": "Cc1ccc(-c2csc3ncnc(NCCCC(=O)O)c23)cc1C",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a toluene core substituted with a fused triazole-thiazole ring system attached via a sulfone linkage. Additionally, it contains a flexible side chain ending with a carboxylate group, which may contribute to its biological activity.",
            "Property Analysis": "The molecule acts as an inhibitor of c-Jun N-terminal kinase 3 (JNK3), potentially by interacting with key residues in the kinase's active site. Its current structure allows for hydrogen bonding and hydrophobic interactions essential for binding efficacy.",
            "Limitation in Source Molecule for Property": "The source molecule exhibits limited binding affinity and selectivity towards JNK3 due to potential flexibility in the side chain, which may reduce binding specificity. Additionally, the presence of multiple rotatable bonds could lead to suboptimal interactions within the binding pocket, and solubility issues might affect bioavailability.",
            "Optimization for Source Molecule": "Enhance binding affinity and selectivity by introducing rigid scaffolds to reduce molecular flexibility, add polar functional groups to form stronger hydrogen bonds, and modify or reduce rotatable bonds to improve binding specificity. Optimize the side chain for better solubility and metabolic stability by incorporating electron-withdrawing groups.",
            "Final Target Molecule": "Cc1ccc(-c2csc3ncnc(NCCCC(=O)O)c23)cc1C(F)F"
        }
    },
    {
        "src_smiles": "O=C(Nc1cnccn1)c1ccccc1NCc1ccncc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an amide linkage connecting a phenyl ring and a pyridine moiety. It features two aromatic rings: a benzene ring and a pyridine ring, providing rigidity and planarity to the molecule. The presence of the amide bond allows for potential hydrogen bonding interactions, and the molecule bears potential sites for receptor binding through its conjugated system.",
            "Property Analysis": "The source molecule exhibits inhibitory activity against JNK3 (c-Jun N-terminal kinase 3), likely due to its ability to interact with the kinase's active site through hydrogen bonding and \u03c0-\u03c0 stacking interactions provided by the aromatic rings. However, the exact binding affinity and selectivity profiles need to be evaluated to determine its efficacy and potential off-target effects.",
            "Limitation in Source Molecule for Property": "Despite its activity, the source molecule may suffer from limited selectivity towards JNK3 over other kinases due to the conserved nature of kinase active sites. Additionally, the molecule may have suboptimal pharmacokinetic properties such as solubility and metabolic stability, which could hinder its effectiveness as a therapeutic agent.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications can be made to increase binding specificity and affinity. Introducing substituents on the aromatic rings could improve interactions with unique amino acid residues in JNK3's active site, thereby enhancing selectivity. Additionally, optimizing the amide linker to minimize metabolic liabilities and enhance solubility can improve pharmacokinetic properties. Incorporating fluorine atoms or other electron-withdrawing groups might also increase binding affinity through stronger hydrogen bonding and electronic interactions.",
            "Final Target Molecule": "O=C(Nc1cnccn1)c1c(F)cc(F)cc(F)c1NCc1ccncc1"
        }
    },
    {
        "src_smiles": "O=c1cc(-c2cccc(O)c2)oc2c1ccc1ccccc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a diketone core connected to multiple aromatic rings, including a phenolic hydroxyl group. The molecular structure features ether linkages and fused aromatic systems, which may contribute to its stability and potential interactions with biological targets.",
            "Property Analysis": "The molecule exhibits characteristics favorable for JNK3 inhibition, such as planar aromatic systems that facilitate \u03c0-\u03c0 stacking interactions and hydroxyl groups that can form hydrogen bonds with the kinase active site. These features may enhance binding affinity and specificity towards JNK3.",
            "Limitation in Source Molecule for Property": "The current structure may have excessive lipophilicity due to multiple aromatic rings, potentially leading to poor solubility and bioavailability. Additionally, the lack of specific functional groups for selective binding might result in off-target effects, reducing the molecule's selectivity for JNK3.",
            "Optimization for Source Molecule": "Introduce polar functional groups to increase aqueous solubility and reduce overall lipophilicity. Modify the aromatic system to enhance selectivity by adding substituents that can form specific hydrogen bonds or interactions with JNK3. Simplify the molecular framework to decrease molecular weight while maintaining essential binding interactions.",
            "Final Target Molecule": "O=C1c(c2cccc(O)c2)Oc2c1ccc(CO)ccc12"
        }
    },
    {
        "src_smiles": "Nc1ccc(C(=O)C=Cc2ccc(-c3ccccc3)cc2)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, Nc1ccc(C(=O)C=Cc2ccc(-c3ccccc3)cc2)cc1, features a central aniline (amino-substituted benzene) core. Attached to the amino group is a benzoyl moiety linked via an \u03b1,\u03b2-unsaturated ketone. This conjugated system extends through a vinyl bond to a biphenyl structure, where one phenyl ring is further substituted with a phenyl group. The molecule exhibits multiple aromatic rings, conjugated double bonds, and a hydrogen-bond donor (NH) which are key for potential biological interactions.",
            "Property Analysis": "The molecule is designed to inhibit c-Jun N-terminal kinase 3 (JNK3), a protein involved in various cellular processes including inflammation and apoptosis. The conjugated system and aromatic rings may facilitate \u03c0-\u03c0 stacking and hydrophobic interactions within the JNK3 active site. Additionally, the carbonyl group can engage in hydrogen bonding with amino acid residues, enhancing binding affinity and inhibitory potency against JNK3.",
            "Limitation in Source Molecule for Property": "The primary limitations of the source molecule include potential lack of selectivity towards JNK3 over other kinases due to its generalized aromatic structure. The \u03b1,\u03b2-unsaturated ketone may also pose metabolic instability or off-target reactivity issues. Furthermore, the molecule's size and complexity might hinder optimal binding orientation and pharmacokinetic properties, potentially reducing its efficacy as a JNK3 inhibitor.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, structural modifications should aim to enhance selectivity and binding affinity while reducing metabolic liabilities. Introducing heteroaromatic substitutions could provide specific interactions with JNK3's unique binding pocket. Modifying or saturating the \u03b1,\u03b2-unsaturated ketone may improve metabolic stability. Adding electron-withdrawing groups on the aromatic rings can strengthen hydrogen bonding and \u03c0-\u03c0 interactions. Additionally, incorporating polar substituents could enhance solubility and favorable interactions within the active site, thereby increasing overall potency and selectivity.",
            "Final Target Molecule": "Nc1ccc(C(=O)C(C)c2cc(ccc2Cl)N)cc1"
        }
    },
    {
        "src_smiles": "O=C(CCCc1ccccc1)Nc1ccc(O)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, O=C(CCCc1ccccc1)Nc1ccc(O)cc1, consists of an amide linkage connecting a valeric acid moiety to a hydroxyphenyl group. It features a three-carbon aliphatic chain attached to a phenyl ring, which is further connected via the amide nitrogen to another phenyl ring bearing a hydroxyl group. This structure provides both hydrophobic and hydrogen-bonding capabilities essential for kinase inhibition.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3) by occupying the ATP-binding pocket, likely forming key hydrogen bonds through the hydroxyl group and engaging in hydrophobic interactions via the phenyl and aliphatic chains. The balance of hydrophobic and polar interactions contributes to its binding affinity and specificity toward JNK3.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from suboptimal selectivity, potentially interacting with other kinases due to the conserved nature of ATP-binding sites. Additionally, the free hydroxyl group could lead to rapid metabolism and reduced bioavailability. The length of the aliphatic chain might not be ideal for optimal binding interactions within the JNK3 active site.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications can include methylation of the hydroxyl group to improve metabolic stability and selectivity. Introducing electron-withdrawing or electron-donating substituents on the phenyl rings can strengthen specific interactions with JNK3. Shortening or rigidifying the aliphatic linker may enhance binding affinity and reduce off-target effects. Additionally, incorporating heteroatoms or bioisosteres could improve pharmacokinetic properties.",
            "Final Target Molecule": "CC(C)C(=O)CCCc1ccccc1Nc1cc(O)cc1C"
        }
    },
    {
        "src_smiles": "O=c1cc(-c2ccccc2Cl)oc2c1ccc1ccccc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a bicyclic compound featuring a central carbonyl group (C=O) attached to two phenyl rings. One phenyl ring is substituted with a chlorine atom, enhancing its hydrophobic characteristics. The molecule includes ether linkages connecting the rings, contributing to its overall planar structure and potential for \u03c0-\u03c0 stacking interactions.",
            "Property Analysis": "The current structure facilitates interaction with the JNK3 kinase through hydrophobic interactions and potential hydrogen bonding via the carbonyl group. The presence of the chlorine substituent may enhance binding affinity by increasing lipophilicity, which is favorable for membrane permeability and interaction with hydrophobic pockets of the enzyme.",
            "Limitation in Source Molecule for Property": "The molecule may exhibit limited selectivity towards JNK3 due to its planar structure, which could allow binding to multiple kinases with similar active sites. Additionally, the bulky chlorine substituent might hinder optimal binding orientation or reduce solubility, potentially affecting bioavailability and specificity.",
            "Optimization for Source Molecule": "Introduce a substituent that enhances selectivity by adding a hydrogen bond acceptor or donor to engage with unique residues in the JNK3 active site. Modify the chlorine substituent to a smaller or more functional group to reduce steric hindrance and improve solubility. Incorporate a meta-substituted group on the phenyl rings to refine binding interactions and increase specificity towards JNK3.",
            "Final Target Molecule": "O=C1cc(-c2ccccc2N)oc2c1ccc1ccccc12"
        }
    },
    {
        "src_smiles": "Cn1c(=O)c(-c2ccccc2)nc2cncnc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a pyrimidinone derivative featuring a methyl group attached to the nitrogen in the heterocyclic ring and a phenyl substituent. The molecule contains a carbonyl group, which is essential for potential hydrogen bonding interactions with JNK3.",
            "Property Analysis": "The molecule demonstrates moderate inhibitory activity against JNK3, with an IC50 value in the micromolar range. Its binding affinity is likely governed by hydrogen bonding and hydrophobic interactions within the JNK3 active site.",
            "Limitation in Source Molecule for Property": "The source molecule exhibits limited selectivity for JNK3 over other kinases, which may lead to off-target effects. Additionally, the potency of inhibition may not be sufficient for effective therapeutic application.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce electron-donating or electron-withdrawing substituents on the phenyl ring to improve hydrophobic interactions and selectivity. Modify the methyl group to a bulkier substituent to increase binding affinity. Additionally, adding hydrogen bond donors or acceptors could strengthen interactions with key residues in the JNK3 active site.",
            "Final Target Molecule": "Cc1c(=O)c(-c2c(cccc2)OC)nc2cncnc21"
        }
    },
    {
        "src_smiles": "Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1Br",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a pyrrole derivative substituted with a bromine atom and two methyl groups on the pyrrole ring. It features a cinnamoyl linkage connecting to a benzamide moiety, which may play a role in its interaction with JNK3 (c-Jun N-terminal kinase 3).",
            "Property Analysis": "The molecule functions as an inhibitor of JNK3, an enzyme implicated in various cellular processes and associated with diseases such as neurodegenerative disorders. Its current structure suggests moderate potency towards JNK3 inhibition, but selectivity and pharmacokinetic properties may need improvement.",
            "Limitation in Source Molecule for Property": "The presence of the bromine atom may lead to metabolic liabilities and reduce selectivity by interacting with off-target kinases. Additionally, the two methyl groups on the pyrrole ring could limit the molecule\u2019s binding conformation, potentially hindering optimal interaction with the JNK3 active site.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibitory activity, replace the bromine atom with a fluorine to improve metabolic stability and reduce off-target interactions. Modify the methyl groups on the pyrrole ring with bulkier or more electron-donating substituents to enhance binding affinity and selectivity. Additionally, optimizing the cinnamoyl linkage by introducing electron-withdrawing groups could strengthen interactions with the kinase\u2019s active site.",
            "Final Target Molecule": "Cc1[nH]c(C=C2C(=O)Nc3ccccc32)C(C)c1F"
        }
    },
    {
        "src_smiles": "c1nc(N2CCCCC2)c2cc[nH]c2n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, represented by SMILES 'c1nc(N2CCCCC2)c2cc[nH]c2n1', consists of a central pyrimidine ring fused with a pyrazole ring. Attached to the pyrimidine nitrogen is a piperidine ring, providing a flexible aliphatic side chain. The molecule features multiple nitrogen atoms which can act as hydrogen bond donors or acceptors, potentially facilitating interactions with the JNK3 kinase active site.",
            "Property Analysis": "The molecule exhibits potential as a JNK3 inhibitor due to its heterocyclic structure, which can engage in key interactions within the kinase's ATP-binding pocket. The presence of the piperidine ring may enhance binding affinity through hydrophobic interactions and improve pharmacokinetic properties by increasing solubility and membrane permeability.",
            "Limitation in Source Molecule for Property": "The primary limitations include possible suboptimal binding specificity and affinity for JNK3, which may arise from the flexible piperidine ring that could lead to weaker or non-specific interactions. Additionally, the absence of electron-withdrawing or donating groups on the pyrazole ring may limit the molecule's ability to form strong hydrogen bonds or ionic interactions essential for potent inhibition.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce electron-withdrawing substituents (e.g., fluorine or nitro groups) on the pyrazole ring to increase hydrogen bonding capability and binding affinity. Rigidify the piperidine ring by incorporating additional ring constraints or substituents to reduce conformational flexibility, thereby improving binding specificity. Additionally, consider adding a second hydrogen bond donor or acceptor on the pyrimidine ring to form stronger interactions with amino acid residues in the JNK3 active site.",
            "Final Target Molecule": "c1nc(N2C1CCCCC1)c2c(F)cc[nH]c2n1"
        }
    },
    {
        "src_smiles": "Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(O)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central heterocyclic ring system incorporating nitrogen and oxygen atoms. It features a dichlorinated benzene ring substituted at the para positions, connected through a carbonyl group to the heterocycle. The molecule includes hydroxyl groups that may participate in hydrogen bonding interactions.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), likely through interactions with the kinase's ATP-binding site. The presence of halogen substituents may contribute to binding affinity and selectivity. Hydrogen bond donors and acceptors in the structure facilitate interactions with key amino acid residues in the enzyme.",
            "Limitation in Source Molecule for Property": "The source molecule may suffer from limited selectivity towards JNK3 over other kinases due to the presence of multiple halogen substituents, which can lead to off-target interactions. Additionally, the molecule might have suboptimal pharmacokinetic properties such as poor solubility or metabolic stability, potentially reducing its efficacy and bioavailability.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce a biphenyl moiety to increase hydrophobic interactions within the binding pocket, replace one chlorine atom with a methyl group to improve selectivity, and add a fluorine atom to increase metabolic stability. Modify the hydroxyl group to a methoxy group to enhance lipophilicity and improve membrane permeability.",
            "Final Target Molecule": "Cn1c(=O)c(-c2c(Cl)c(c3ccccc3)c2Cl)cc2cnc(O)nc21C"
        }
    },
    {
        "src_smiles": "Nc1nccc(-c2ccc3ccccc3c2)n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, Nc1nccc(-c2ccc3ccccc3c2)n1, consists of a diazole core with two nitrogen atoms in the ring. It is substituted with a biphenyl moiety, providing multiple aromatic rings that can engage in \u03c0-\u03c0 stacking and hydrophobic interactions.",
            "Property Analysis": "The molecule exhibits potential as a kinase inhibitor due to its planar aromatic system, which can facilitate binding to the ATP-binding site of JNK3. The presence of nitrogen atoms may allow for hydrogen bonding with amino acid residues in the active site, enhancing binding affinity.",
            "Limitation in Source Molecule for Property": "The current structure may lack sufficient hydrogen bond donors and may have suboptimal binding interactions, potentially leading to lower selectivity and affinity for JNK3. Additionally, the biphenyl moiety might lead to decreased solubility and increased metabolic liability.",
            "Optimization for Source Molecule": "Introduce a hydrogen bond donor to enhance interactions with JNK3 active site residues. Modify the biphenyl moiety to include polar substituents to improve solubility and reduce metabolic liability. Incorporate a methyl group to increase binding specificity and affinity.",
            "Final Target Molecule": "Nc1nccc(NC)c2ccc(c3ccccc3)c2n1"
        }
    },
    {
        "src_smiles": "CC(C)n1cnc2c(Nc3cccc(Cl)c3)ncnc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule CC(C)n1cnc2c(Nc3cccc(Cl)c3)ncnc21 consists of a dimethylamino group attached to a fused triazine and pyrazine ring system. The molecule includes a chlorophenyl substituent, which could contribute to its pharmacological activity through hydrophobic interactions.",
            "Property Analysis": "JNK3 (c-Jun N-terminal kinase 3) is a kinase involved in various cellular processes and is a target for treating neurological disorders. Effective inhibitors typically interact with the ATP-binding site of JNK3, often utilizing hydrogen bond donors or acceptors and hydrophobic regions to enhance binding affinity and specificity.",
            "Limitation in Source Molecule for Property": "The current structure may lack sufficient hydrogen bond donors/acceptors necessary for optimal interaction with the ATP-binding site of JNK3. Additionally, the hydrophobic chlorine substituent might limit the molecule's ability to engage in deeper hydrophobic pockets within the kinase, potentially reducing binding affinity and selectivity.",
            "Optimization for Source Molecule": "Introduce additional hydrogen bond acceptors or donors to enhance interactions with the JNK3 active site. Modify the chlorophenyl group to include electron-withdrawing groups that can improve binding affinity. Additionally, adjust the fused ring system to increase conformational flexibility, allowing better accommodation within the kinase binding pocket.",
            "Final Target Molecule": "CC(C)n1cnc2c(Nc3ccc(cc3)C(=O)O)c(nc21)"
        }
    },
    {
        "src_smiles": "CCC(C)Nc1ncnc2cc(OC)c(OC)cc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, CCC(C)Nc1ncnc2cc(OC)c(OC)cc12, consists of a piperazine ring connected to a di-methoxy-substituted naphthalene core. The piperazine serves as a flexible linker, while the naphthalene moiety provides a planar aromatic system that may facilitate \u03c0-\u03c0 stacking interactions with the JNK3 kinase active site. The methoxy groups are positioned to potentially engage in hydrogen bonding or hydrophobic interactions.",
            "Property Analysis": "The molecule exhibits features typical of kinase inhibitors, including a basic nitrogen in the piperazine ring that can form hydrogen bonds with hinge residues of JNK3. The aromatic naphthalene ring may enhance binding affinity through hydrophobic and \u03c0-\u03c0 interactions. The methoxy substituents increase solubility and may contribute to binding specificity.",
            "Limitation in Source Molecule for Property": "The piperazine linker may introduce excessive flexibility, potentially reducing binding affinity and selectivity for JNK3. The di-methoxy substitution on the naphthalene ring could lead to metabolic instability and off-target interactions due to the electron-donating nature of methoxy groups, which may affect the compound's overall specificity and potency.",
            "Optimization for Source Molecule": "Introduce rigidity to the linker by replacing piperazine with a more constrained scaffold such as piperidine or a fused heterocycle to enhance binding specificity and affinity. Modify the naphthalene core by replacing one or both methoxy groups with electron-withdrawing substituents like fluorine or trifluoromethyl groups to improve metabolic stability and reduce off-target interactions. Additionally, exploring different aromatic substitutions could enhance specific interactions with the JNK3 active site.",
            "Final Target Molecule": "CC(C)N1CCCCC1c2ncnc3cc(F)c(F)cc23"
        }
    },
    {
        "src_smiles": "c1ccc(Nc2ccc(Oc3nccnc3C3CCOC3)cc2)nc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a substituted benzene derivative featuring two amino linkages. One substituent includes an ether-linked triazole moiety, while the other contains a flexible cyclic ether structure. The molecule possesses multiple aromatic rings and heteroatoms, which may contribute to its binding interactions with biological targets such as JNK3.",
            "Property Analysis": "The molecule demonstrates potential inhibitory activity against JNK3, attributed to its ability to interact with the kinase's active site through hydrogen bonding and pi-stacking interactions. However, the current binding affinity and selectivity may need improvement to enhance its therapeutic efficacy.",
            "Limitation in Source Molecule for Property": "The existing structure may lack specific functional groups that form additional critical interactions within the JNK3 active site, potentially limiting binding affinity and selectivity. The presence of bulky substituents could also hinder optimal positioning within the binding pocket.",
            "Optimization for Source Molecule": "Introduce functional modifications such as adding hydrogen bond donors or acceptors to enhance interactions with key residues in JNK3. Incorporate small substituents to reduce steric hindrance and improve binding conformation. Consider adding fluorine atoms to increase metabolic stability and binding affinity.",
            "Final Target Molecule": "c1ccc(Nc2ccc(Oc3nccnc3C3CCOC3F)cc2)nc1"
        }
    },
    {
        "src_smiles": "O=c1cc(N2CCOCC2)oc2c(OCc3ccccc3)cccc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, O=c1cc(N2CCOCC2)oc2c(OCc3ccccc3)cccc12, consists of a central benzopyran scaffold with a ketone functional group. It features a piperazine ring (N2CCOCC2) attached to the benzene ring, and a methoxyphenyl substituent (OCc3ccccc3) linked to the pyran ring. The molecule has multiple aromatic rings and ether linkages, contributing to its overall rigidity and potential for hydrogen bonding.",
            "Property Analysis": "The molecule demonstrates potential as a JNK3 inhibitor due to its aromatic system, which may facilitate \u03c0-\u03c0 interactions with the kinase active site. The presence of the ketone group could act as a hydrogen bond acceptor, enhancing binding affinity. Additionally, the methoxy groups may improve solubility and pharmacokinetic properties.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from limited specificity towards JNK3 due to similar binding sites in other kinases, potentially leading to off-target effects. The molecule's rigidity might restrict its ability to adapt to conformational changes in the kinase. Moreover, the lack of specific interactions essential for high-affinity binding to JNK3 could limit its inhibitory potency.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce substituents that can form additional hydrogen bonds or hydrophobic interactions unique to the JNK3 active site. Modifying the piperazine ring to include an amine or other functional groups could increase binding specificity. Introducing a linker or spacer between the benzopyran core and the methoxyphenyl group may provide the necessary flexibility for optimal binding. Additionally, exploring bioisosteric replacements for the ketone could improve metabolic stability and binding affinity.",
            "Final Target Molecule": "O=C1CCN(CCO)C2=CC(O)=CC=C12C3=CC(OC)=CC=C3N"
        }
    },
    {
        "src_smiles": "COc1ccc(Nc2nccc(N3CCN(C)CC3)n2)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxy-substituted benzene ring connected to a complex tricyclic structure containing multiple nitrogen atoms. It features an amide linkage that connects the benzene ring to a bicyclic aromatic system fused with piperazine rings, which may contribute to its biological activity.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), an enzyme involved in various cellular processes including inflammation and apoptosis. Effective inhibition of JNK3 is desirable for therapeutic applications in neurodegenerative diseases and inflammatory disorders.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from suboptimal specificity and potency against JNK3, possibly due to limited interactions within the JNK3 binding pocket. Additionally, the molecule's solubility and bioavailability might be inadequate for effective in vivo applications.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, structural modifications could include introducing electron-withdrawing groups to increase binding affinity, optimizing the tricyclic system for a better fit within the JNK3 binding site, and improving solubility by adding polar functional groups. Additionally, modifying the piperazine moieties to reduce potential off-target interactions could increase specificity.",
            "Final Target Molecule": "COc1ccc(Nc2nccc(N3CCN(C)CC3)n2)cc1"
        }
    },
    {
        "src_smiles": "Nc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, represented by the SMILES string Nc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1, consists of a central pyrimidine ring substituted with an aniline moiety. Attached to the pyrimidine is a thioether-linked aromatic ring bearing a chlorine substituent. This structure provides multiple sites for potential hydrogen bonding and hydrophobic interactions, which are crucial for kinase inhibition.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3). The presence of electron-withdrawing groups such as chlorine may enhance binding affinity through interactions with the kinase's active site. The thioether linkage provides flexibility, potentially allowing the molecule to adapt to the binding pocket of JNK3.",
            "Limitation in Source Molecule for Property": "While the source molecule shows activity against JNK3, its potency and selectivity may be suboptimal. The existing substituents might not form sufficient interactions within the JNK3 active site, and the molecular framework may limit further optimization. Additionally, the chlorine substituent could contribute to off-target effects, reducing selectivity.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications could include introducing additional hydrogen bond donors or acceptors to strengthen interactions with the kinase's active site. Replacing the chlorine with a more favorable substituent could improve selectivity and reduce off-target binding. Additionally, increasing the rigidity of the molecular framework may enhance binding affinity by reducing entropy loss upon binding.",
            "Final Target Molecule": "Nc1ccc(Nc2nc(-c3ccc(F)cc3)cs2)cc1"
        }
    },
    {
        "src_smiles": "COc1cc2ncnc(Nc3ccc(N)cc3)c2cc1OC",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, COc1cc2ncnc(Nc3ccc(N)cc3)c2cc1OC, features a symmetrical structure with methoxy groups attached to both aromatic rings. It comprises a bicyclic core formed by the fusion of two aromatic rings with a pyrimidine-like nitrogen-containing heterocycle. Additionally, it has an aniline moiety linked to the central heterocycle, providing potential sites for hydrogen bonding.",
            "Property Analysis": "The molecule exhibits potential as a JNK3 inhibitor due to its aromatic systems which can facilitate \u03c0-\u03c0 stacking interactions within the kinase's active site. The amino groups are likely to form hydrogen bonds with key residues in JNK3, enhancing binding affinity. Methoxy substituents may improve the molecule\u2019s solubility and electronic distribution, contributing to overall inhibitory activity.",
            "Limitation in Source Molecule for Property": "The source molecule may lack sufficient selectivity towards JNK3 over other kinases, potentially leading to off-target effects. The methoxy groups, while enhancing solubility, might reduce metabolic stability, making the compound susceptible to rapid degradation. Additionally, the current substitution pattern may not optimally interact with all critical residues within the JNK3 binding pocket.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, introduce substituents that enhance binding specificity, such as fluorine atoms or halogens, which can form additional interactions within the active site. Replace one of the methoxy groups with a more metabolically stable group like a trifluoromethyl to enhance stability. Modify the aniline moiety by adding ortho-substituents to increase hydrogen bonding potential and improve selectivity towards JNK3.",
            "Final Target Molecule": "COc1cc2ncnc(Nc3cc(CF3)cc(N)c3)c2cc1OC"
        }
    },
    {
        "src_smiles": "NC(=O)c1cccc2c(NCc3cccc(F)c3)ncnc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule NC(=O)c1cccc2c(NCc3cccc(F)c3)ncnc12 consists of a pyrimidine core fused to a pyrazole ring, substituted with an amide group and an N-alkyl chain containing a fluorophenyl moiety. The molecule features hydrogen bond acceptors, aromatic systems contributing to hydrophobic interactions, and a fluorine atom that may enhance metabolic stability and binding affinity.",
            "Property Analysis": "The molecule acts as an inhibitor of c-Jun N-terminal kinase 3 (JNK3) by likely engaging in hydrogen bonding and hydrophobic interactions within the kinase's active site. The presence of the fluorophenyl group may improve binding affinity and selectivity, while the overall structure provides a scaffold suitable for kinase inhibition.",
            "Limitation in Source Molecule for Property": "The current scaffold may lack optimal selectivity towards JNK3 over other kinases, potentially leading to off-target effects. Additionally, the molecular conformation may not fully exploit all binding interactions within JNK3, and the presence of the amide linker could limit metabolic stability and cell permeability.",
            "Optimization for Source Molecule": "Introduce substituents that enhance selectivity and binding affinity towards JNK3 by targeting unique interactions within its active site. Modify the N-alkyl chain to improve pharmacokinetic properties such as solubility and permeability, possibly by introducing polar functional groups. Replace or modify the fluorophenyl moiety to engage additional interactions, such as hydrogen bonds or \u03c0-\u03c0 stacking, to stabilize the inhibitor within the kinase pocket. Consider bioisosteric replacements for the amide linkage to enhance metabolic stability.",
            "Final Target Molecule": "NC(=O)c1cccc2c(NC(C)cc3ccc(F)cc3)ncnc12"
        }
    },
    {
        "src_smiles": "CC(C)n1cnc2c(NCc3ccccc3)nc(N)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features an isopropyl group attached to a purine core, which is further substituted with an amino-linked benzyl moiety. The purine scaffold is crucial for kinase inhibition, providing a planar structure that can interact with the ATP-binding site of JNK3.",
            "Property Analysis": "Currently, the molecule acts as a moderate inhibitor of c-Jun N-terminal kinase 3 (JNK3), showing potential in reducing pathological phosphorylation events mediated by JNK3. The presence of the amino-benzyl group may contribute to binding affinity through hydrogen bonding and pi-stacking interactions.",
            "Limitation in Source Molecule for Property": "The source molecule may exhibit suboptimal selectivity, potentially inhibiting other kinases due to the conserved nature of ATP-binding sites. Additionally, the isopropyl group may limit further hydrogen bonding interactions, and the overall molecular flexibility could be reduced, affecting binding dynamics.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce a substituent that improves selectivity and binding affinity. Adding a methyl group to the amino-benzyl moiety could increase hydrophobic interactions within the JNK3 active site. Alternatively, incorporating a polar functional group may form additional hydrogen bonds, enhancing specificity. Modifying the isopropyl group to a bulkier or more flexible substituent could also improve fit and interactions within the binding pocket.",
            "Final Target Molecule": "CC(C)n1cnc2c(NCc3cc(ccc3)C)nc(NC)nc21"
        }
    },
    {
        "src_smiles": "COc1nc(NC(C)=O)cc(N)c1C#N",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a pyridine ring substituted with a methoxy group (\u2013OCH\u2083), an amide linkage (\u2013NC(C)=O), a primary amine (\u2013NH\u2082), and a nitrile group (\u2013C\u2261N). The presence of both electron-donating and electron-withdrawing groups provides sites for potential hydrogen bonding and \u03c0-\u03c0 interactions, contributing to the molecule\u2019s overall polarity and binding versatility.",
            "Property Analysis": "The molecule demonstrates inhibitory activity against c-Jun N-terminal kinase 3 (JNK3). The combination of hydrogen bond donors and acceptors facilitates interactions with the kinase\u2019s active site, while the aromatic pyridine ring and nitrile group may engage in \u03c0-\u03c0 stacking and other non-covalent interactions essential for effective inhibition.",
            "Limitation in Source Molecule for Property": "The nitrile group, while useful for binding, may limit the molecule\u2019s flexibility and reduce selectivity due to its strong electron-withdrawing nature. Additionally, the methoxy group may not optimally participate in hydrogen bonding within the JNK3 active site, potentially hindering maximal binding affinity and specificity.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibitory activity, modify the nitrile group to a more versatile functional group such as an amide or a trifluoromethyl group to improve binding interactions and selectivity. Replace the methoxy group with a hydroxyl or amino group to increase hydrogen bonding capacity. Additionally, introducing a small hydrophobic substituent on the pyridine ring could enhance \u03c0-\u03c0 stacking interactions with the kinase.",
            "Final Target Molecule": "COc1nc(NC(C)=O)cc(N)c1C(F)(F)F"
        }
    },
    {
        "src_smiles": "CS(=O)(=O)Nc1ccc2ccc3ncc(Cl)cc3c(=O)c2c1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a sulfonamide group (CS(=O)(=O)N) linked to a phenyl ring, which is fused to a multi-ring heterocyclic structure incorporating a chlorinated pyridine moiety and a carbonyl group. The presence of nitrogen heteroatoms and the chlorine substituent may contribute to binding interactions with JNK3.",
            "Property Analysis": "The molecule exhibits potential JNK3 inhibitory activity likely due to its ability to interact with the ATP-binding site of the kinase through hydrogen bonds and hydrophobic interactions facilitated by the sulfonamide and chloro-substituted aromatic rings.",
            "Limitation in Source Molecule for Property": "Limited selectivity towards JNK3 over other kinases may be a concern due to the conserved nature of ATP-binding pockets. Additionally, the molecule may have suboptimal pharmacokinetic properties such as solubility and bioavailability.",
            "Optimization for Source Molecule": "Introduce substituents that can form additional hydrogen bonds or occupy unique pockets in JNK3 to enhance selectivity. Modify the sulfonamide group to improve binding affinity and reduce off-target interactions. Incorporate polar groups to enhance solubility without compromising binding interactions.",
            "Final Target Molecule": "CS(=O)(=O)N(C1=CC=C(C=C1)C2=CC(Cl)=NC3=CC=CC=C3C2=O)C)C4=CC=CC=C4O"
        }
    },
    {
        "src_smiles": "Nc1c(C(=O)c2cccc(C(O)CO)c2)cnn1-c1ccc(F)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a pyrimidine core substituted with an amino group and a ketone-linked phenyl ring containing a dihydroxypropyl side chain. Additionally, it includes a triazine ring connected to a fluorophenyl group. The structure comprises multiple aromatic rings, hydroxyl groups, and a fluorine substituent, which contribute to its overall polarity and potential hydrogen bonding capabilities.",
            "Property Analysis": "The molecule acts as an inhibitor of c-Jun N-terminal kinase 3 (JNK3), likely interacting with the ATP-binding site of the kinase. The presence of hydrogen bond donors (hydroxyl groups) and acceptors, along with aromatic systems, facilitates strong binding affinity and specificity towards JNK3, which is crucial for its inhibitory activity.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from limited selectivity against other kinases, potential metabolic instability due to multiple hydroxyl groups, and suboptimal cell permeability. The presence of a fluorine atom, while beneficial for metabolic stability, might adversely affect solubility and reduce binding specificity.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications should focus on increasing selectivity and binding affinity while improving pharmacokinetic properties. This can include introducing substituents that strengthen hydrogen bonding within the JNK3 active site, reducing the number of hydroxyl groups to enhance metabolic stability, and adjusting the lipophilicity to improve cell permeability. For example, replacing one hydroxyl group with a methyl ether could reduce polarity without significantly impacting binding.",
            "Final Target Molecule": "Nc1nc(C(=O)c2cccc(COC)cc2)cnn1-c1ccc(F)cc1"
        }
    },
    {
        "src_smiles": "O=c1cc(C2CCCCC2)oc2c1ccc1ccccc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a quinone core structure with a cyclohexyl substituent attached to the aromatic ring. The presence of the carbonyl group and multiple aromatic rings suggests potential sites for hydrogen bonding and hydrophobic interactions.",
            "Property Analysis": "The molecule exhibits potential inhibitory activity against c-Jun N-terminal kinase 3 (JNK3) due to its aromatic system and carbonyl functionalities, which may interact with the active site of JNK3 through \u03c0-\u03c0 stacking and hydrogen bonding.",
            "Limitation in Source Molecule for Property": "The bulky cyclohexyl group may hinder optimal binding to the JNK3 active site, potentially reducing the inhibitor's potency. Additionally, the lack of polar functional groups might limit specific interactions necessary for enhanced binding affinity.",
            "Optimization for Source Molecule": "Introduce a smaller, more polar substituent in place of the cyclohexyl group to reduce steric hindrance and allow for hydrogen bonding with JNK3. Incorporate a hydroxyl or amino group to enhance hydrogen bonding capabilities and improve solubility, thereby increasing binding affinity and inhibitory potency.",
            "Final Target Molecule": "O=c1cc(CN)oc2c1ccc1ccccc12"
        }
    },
    {
        "src_smiles": "c1ccc(COc2ccc(OCCn3cnc4ccccc43)cc2)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a benzene ring substituted with a methoxy group and an ether-linked side chain. This side chain connects to another aromatic ring that is further substituted with an ethoxy group and a triazole-fused multi-ring system. The overall structure provides multiple aromatic surfaces and ether linkages, which may facilitate interactions with the JNK3 kinase active site.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3). The presence of the triazole moiety and the aromatic rings likely contributes to binding affinity through hydrogen bonding and \u03c0-\u03c0 stacking interactions within the JNK3 active site. Ether linkages may enhance solubility and proper positioning of the molecule.",
            "Limitation in Source Molecule for Property": "The current structure may have suboptimal binding affinity and selectivity for JNK3, potentially due to insufficient hydrogen bonding capabilities or lack of specific functional groups that enhance interactions within the active site. Additionally, the flexible ether linkages might reduce binding specificity.",
            "Optimization for Source Molecule": "Introduce electron-withdrawing groups, such as fluorine or chlorine, on the aromatic rings to enhance binding interactions and increase potency. Modify the ether linkages to incorporate more rigid structures, improving binding specificity. Enhance hydrogen bonding capacity by adding functional groups like hydroxyl or amine substituents. Optimize the triazole moiety to better fit the JNK3 binding pocket, potentially increasing selectivity.",
            "Final Target Molecule": "c1ccc(CCOc2ccc(OCCn3cnc4c(F)cccc4n3)cc2)cc1"
        }
    },
    {
        "src_smiles": "Cc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a chlorinated purine derivative featuring a fused bicyclic structure. It comprises a pyrimidine ring fused with an imidazole ring, substituted with two chlorine atoms on the aromatic ring and a methylated amine group attached to the carbonyl. This structure allows for potential hydrogen bonding and hydrophobic interactions, which are crucial for kinase inhibition.",
            "Property Analysis": "The molecule exhibits inhibitory activity against JNK3 (c-Jun N-terminal kinase 3), a kinase involved in various cellular processes including inflammation and apoptosis. The presence of chlorine atoms may enhance binding affinity through halogen bonding and increase lipophilicity, potentially improving cell membrane permeability and metabolic stability.",
            "Limitation in Source Molecule for Property": "The high degree of chlorination might lead to decreased selectivity, increasing the risk of off-target effects. Additionally, the molecule may suffer from limited solubility and suboptimal binding interactions due to restricted conformational flexibility, potentially hindering optimal engagement with the JNK3 active site.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, the molecule can be optimized by reducing the number of chlorine atoms to enhance selectivity and decrease potential toxicity. Introducing heteroatoms or polar functional groups could improve solubility and provide additional hydrogen bonding opportunities. Modifying the aromatic system to allow greater conformational flexibility may enhance binding affinity and specificity towards the JNK3 active site.",
            "Final Target Molecule": "Cc1ncc2cc(-c3ccc(Cl)cc3)c(=O)nc(C)c2n1"
        }
    },
    {
        "src_smiles": "c1cnc(-c2c[nH]c3ncnc(N4CCOCC4)c23)cn1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a triazole core connected to a piperazine ring through a fused heteroaromatic system. It contains multiple nitrogen atoms which can participate in hydrogen bonding and pi-stacking interactions, potentially enhancing binding affinity to the JNK3 active site.",
            "Property Analysis": "The molecule acts as a JNK3 inhibitor by interacting with the kinase's ATP-binding pocket. Key interactions include hydrogen bonds from the triazole and piperazine nitrogen atoms, as well as hydrophobic interactions from the aromatic rings, contributing to its inhibitory potency.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from limited selectivity towards JNK3 due to similar binding pockets in related kinases. Additionally, the piperazine moiety may introduce conformational flexibility, potentially reducing binding specificity and affecting pharmacokinetic properties.",
            "Optimization for Source Molecule": "Enhance selectivity and binding affinity by introducing electron-withdrawing groups on the triazole ring to strengthen hydrogen bonding with JNK3. Replace the flexible piperazine ring with a more rigid linker, such as a pyridine or sulfonamide group, to improve binding specificity and reduce off-target interactions.",
            "Final Target Molecule": "c1cnc(-c2c[nH]c3ncnc(N4CCOC4)C(F)c23)cn1"
        }
    },
    {
        "src_smiles": "Fc1ccc(-c2nc[nH]c2-c2ccncc2)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a fluorophenyl ring attached to an amidine-linked diheteroaryl system. The fluorine atom on the phenyl ring may contribute to binding affinity through halogen bonding, while the amidine group provides potential for hydrogen bonding interactions with the JNK3 active site.",
            "Property Analysis": "The molecule exhibits structural features conducive to kinase inhibition, including a planar aromatic system for \u03c0-\u03c0 stacking interactions and an amidine group capable of forming hydrogen bonds. However, the current configuration may offer limited binding affinity and selectivity towards JNK3.",
            "Limitation in Source Molecule for Property": "The source molecule may lack optimal interactions with key residues in the JNK3 active site, resulting in suboptimal inhibitory potency. Additionally, the absence of specific substituents could lead to reduced selectivity, increasing the likelihood of off-target effects.",
            "Optimization for Source Molecule": "Introduce substituents on the phenyl and heteroaryl rings to enhance binding interactions with JNK3 active site residues. Modify the amidine group to improve hydrogen bonding capability and specificity. Incorporate lipophilic groups to enhance cell permeability and overall pharmacokinetic properties, thereby increasing potency and selectivity.",
            "Final Target Molecule": "Fc1ccc(-c2nc[nH]c2-c2ccncc2)-c3cc(ccc3C)N"
        }
    },
    {
        "src_smiles": "O=C(O)CCSc1ccc2ccccc2n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, represented by the SMILES notation O=C(O)CCSc1ccc2ccccc2n1, consists of a carboxylic acid group connected via a two-carbon linker to a thioether linkage. The aromatic system includes a fused bicyclic ring with a nitrogen atom, indicating potential for hydrogen bonding and \u03c0-\u03c0 interactions. The thioether group contributes to the molecule's overall lipophilicity.",
            "Property Analysis": "The molecule exhibits potential JNK3 inhibitory activity likely through interactions within the kinase's active site. The carboxyl group may form hydrogen bonds with key residues, while the aromatic rings facilitate hydrophobic interactions and \u03c0-\u03c0 stacking, enhancing binding affinity and selectivity towards JNK3.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from limited selectivity, possibly interacting with other kinases due to its broad hydrophobic and hydrogen-bonding capabilities. Additionally, the thioether linkage may be susceptible to metabolic oxidation, reducing the molecule's stability and bioavailability.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce substituents that increase selectivity by targeting unique residues in the JNK3 active site. Replace the thioether linkage with a more metabolically stable ether or amide bond to improve pharmacokinetic properties. Incorporate electron-donating or withdrawing groups on the aromatic rings to fine-tune binding affinity and specificity.",
            "Final Target Molecule": "O=C(O)CCNC1=CC=C(C=C1)N"
        }
    },
    {
        "src_smiles": "O=C(O)c1cnc2c(ccc3ccccc32)c1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule O=C(O)c1cnc2c(ccc3ccccc32)c1 features a benzoic acid moiety fused with a tricyclic aromatic system. This structure includes a central pyridine ring fused to two benzene rings, resulting in a rigid and planar conformation that may facilitate stacking interactions with biological targets.",
            "Property Analysis": "The compound exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), an enzyme implicated in various neurological disorders. The current activity is likely due to the molecule's ability to interact with the ATP-binding site of JNK3 through \u03c0-\u03c0 stacking and hydrogen bonding interactions provided by the aromatic rings and the carboxylic acid group.",
            "Limitation in Source Molecule for Property": "The presence of the carboxylic acid group may confer poor cell membrane permeability and reduced bioavailability, limiting the compound's effectiveness in vivo. Additionally, the flat aromatic system may lead to non-selective binding, increasing the risk of off-target effects and reducing selectivity towards JNK3.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications could include the introduction of substituents that improve membrane permeability, such as methyl or ethyl groups adjacent to the carboxylic acid. Adding polar or hydrogen-bond donating/accepting groups could enhance specific interactions with JNK3 residues, increasing binding affinity and selectivity. Additionally, reducing planar aromaticity by introducing steric bulk could improve selectivity by minimizing interactions with other kinases.",
            "Final Target Molecule": "O=C(O)C(c1cnc2c(ccc3ccccc32)c1)(C)C"
        }
    },
    {
        "src_smiles": "Cc1cc(C)n(-c2ccc(C(=O)Nc3sccc3C(N)=O)cc2)n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a benzene ring substituted with a methyl group and a secondary aromatic amine. It features a thiophene moiety linked via an amide bond, incorporating an additional amide functional group. The molecule has multiple hydrogen bond donors and acceptors, contributing to its potential binding interactions.",
            "Property Analysis": "The molecule exhibits moderate affinity for JNK3 due to its ability to form hydrogen bonds and hydrophobic interactions within the kinase's active site. The presence of the thiophene ring may contribute to \u03c0-\u03c0 stacking interactions, enhancing binding stability. However, the molecule's solubility and selectivity may impact its overall efficacy as a JNK3 inhibitor.",
            "Limitation in Source Molecule for Property": "The primary limitations include suboptimal selectivity against other kinases, which could lead to off-target effects, and potentially limited cell permeability due to multiple hydrogen bond donors. Additionally, the molecular weight and lipophilicity might impede favorable pharmacokinetic properties.",
            "Optimization for Source Molecule": "Introduce substituents that enhance selectivity for JNK3 by exploiting unique interactions within its binding pocket. Reduce the number of hydrogen bond donors to improve cell permeability and pharmacokinetic properties. Modify the thiophene ring to a more rigid or electron-deficient heterocycle to enhance binding affinity and selectivity. Optimize lipophilicity to balance solubility and membrane permeability.",
            "Final Target Molecule": "Cc1cc(C)n(-c2ccc(C(=O)Nc3coc3C(N)=O)cc2)n1"
        }
    },
    {
        "src_smiles": "Cc1[nH]c2ccc(Cl)cc2c1-c1ccnc(N2CCCC2)n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, Cc1[nH]c2ccc(Cl)cc2c1-c1ccnc(N2CCCC2)n1, consists of a central tricyclic core featuring fused aromatic rings and a piperidine moiety. It has a methyl group attached to a nitrogen-containing aromatic ring, a chlorine substituent on one of the phenyl rings, and a secondary amine linkage connected to a piperidine ring. The presence of multiple nitrogen atoms suggests potential hydrogen bonding capabilities, while the chlorine atom may contribute to lipophilicity and binding interactions.",
            "Property Analysis": "The molecule exhibits potential as a JNK3 inhibitor due to its structural features that allow for interactions with the ATP-binding site of the kinase. The aromatic rings and the piperidine moiety likely engage in \u03c0-\u03c0 stacking and hydrophobic interactions, respectively, which are critical for binding affinity. However, the current activity may be limited by insufficient selectivity towards JNK3 over other kinases and suboptimal binding affinity.",
            "Limitation in Source Molecule for Property": "The primary limitations of the source molecule in terms of JNK3 inhibition include moderate binding affinity and lack of selectivity, which could lead to off-target effects. Additionally, the molecule\u2019s solubility and metabolic stability may be suboptimal, potentially affecting its bioavailability and pharmacokinetic profile.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibitory properties, the optimization strategy involves introducing substituents that can form additional hydrogen bonds or hydrophobic interactions within the JNK3 active site to improve binding affinity. Replacing the chlorine atom with a fluorine or a methylsulfonyl group could increase selectivity and metabolic stability. Modifying the piperidine ring to a more rigid cyclic amine might enhance binding specificity. Additionally, optimizing the linker between the aromatic rings can improve the overall conformation for better target engagement.",
            "Final Target Molecule": "Cc1[nH]c2ccc(F)cc2c1-c1ccnc(N2CCOCC2)n1"
        }
    },
    {
        "src_smiles": "CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OC(C)C)c2)[nH]1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a thioether linkage connecting a pyrimidine core substituted with a fluorophenyl group and a substituted pyridine ring with a methoxyisopropyl group. The presence of the pyrimidine and pyridine rings provides potential for hydrogen bonding and pi-stacking interactions, which are crucial for kinase inhibition.",
            "Property Analysis": "The molecule demonstrates moderate inhibitory activity against JNK3 due to its ability to interact with the ATP-binding site of the kinase. The fluorine substituent enhances binding affinity through electronic effects, while the methoxyisopropyl group contributes to solubility and membrane permeability.",
            "Limitation in Source Molecule for Property": "Despite its activity, the source molecule suffers from suboptimal selectivity for JNK3 over other kinases, potentially leading to off-target effects. Additionally, the thioether linkage may be prone to metabolic instability, reducing the molecule's overall efficacy and half-life.",
            "Optimization for Source Molecule": "To improve selectivity and metabolic stability, the thioether linkage can be replaced with a more robust bioisostere, such as a methylene or ethylene bridge. Introducing bulky or specific substituents on the pyrimidine core may enhance selectivity for JNK3. Adding electron-withdrawing groups on the pyridine ring could strengthen binding interactions within the kinase domain.",
            "Final Target Molecule": "CC(C)OCOc2ccnc(Cc1nc(-c3ccc(F)cc3)cc1)c2"
        }
    },
    {
        "src_smiles": "CCn1ncc(C2=NOC(C(=O)Nc3cccc(C(C)=O)c3)C2)c1C",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a pyridine ring substituted with a methyl group and connected to an ether-functionalized side chain containing an amide bond. This amide is further linked to a substituted phenyl ring bearing a ketone group. The structure features multiple aromatic systems and potential hydrogen bond donors and acceptors, which are critical for JNK3 inhibition.",
            "Property Analysis": "The molecule exhibits moderate inhibitory activity against JNK3. Its physicochemical properties, including molecular weight, logP, and solubility, are within acceptable ranges for kinase inhibitors, but there is potential for improved binding affinity and selectivity.",
            "Limitation in Source Molecule for Property": "The current structure may lack optimal functional groups necessary for enhanced binding interactions with JNK3, potentially resulting in limited potency and selectivity. Additionally, the molecule might have suboptimal pharmacokinetic properties that could affect its efficacy.",
            "Optimization for Source Molecule": "Introduce electron-withdrawing groups such as fluorine to enhance binding affinity through stronger interactions. Modify the amide linkage to improve hydrogen bonding with the JNK3 active site. Incorporate additional aromatic substituents to increase selectivity and optimize the overall binding conformation.",
            "Final Target Molecule": "CCn1ncc(C2=NOC(C(=O)Nc3ccc(F)c(C)=O)c3)C2)c1C"
        }
    },
    {
        "src_smiles": "O=c1cc(C2CCCCC2)oc2c1ccc1ccccc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a fused aromatic system with a ketone group and a cyclohexyl substituent. Specifically, it consists of a benzophenone core where one aromatic ring is fused with a cyclohexyl group, creating a polycyclic structure. This arrangement provides a combination of hydrophobic regions and a carbonyl group, which can interact with biological targets.",
            "Property Analysis": "The molecule exhibits moderate inhibition of c-Jun N-terminal kinase 3 (JNK3). The presence of the cyclohexyl group and the ketone functionality likely contribute to its binding affinity through hydrophobic interactions and potential hydrogen bonding with the kinase's active site.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from limited selectivity and potency due to the lack of specific interactions required for optimal JNK3 binding. Additionally, the rigidity of the fused aromatic system might restrict necessary conformational flexibility for better binding efficiency.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce polar functional groups such as amino or hydroxyl groups to form additional hydrogen bonds with the kinase. Modify the cyclohexyl ring to a more rigid or functionalized substituent to improve binding specificity. Incorporating heteroatoms could also enhance interactions within the active site and increase overall binding affinity.",
            "Final Target Molecule": "O=C1cc(NC)C2OC2c1ccc1ccccc12"
        }
    },
    {
        "src_smiles": "COC(=O)c1ccc(=O)n(Cc2ccc3c(c2)OCO3)c1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a benzamide derivative featuring a methyl ester group attached to a benzene ring, a ketone functional group, and a cyclic ether moiety. The structure includes a COC(=O) moiety linked to a benzene ring substituted with an amide and an ether bridge forming a cyclic structure.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), which is implicated in various neurological disorders. Its ester and amide functionalities facilitate binding interactions with the JNK3 enzyme, contributing to its inhibitory effect.",
            "Limitation in Source Molecule for Property": "The source molecule may have limited binding affinity and selectivity for JNK3 due to steric hindrance from bulky substituents, which can impede optimal interactions within the kinase's active site. Additionally, the ester group may be prone to metabolic hydrolysis, reducing the molecule's in vivo stability and efficacy.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, the methyl ester group is replaced with a more metabolically stable bioisostere to prevent hydrolysis. Bulky substituents are streamlined to reduce steric hindrance, improving binding affinity and selectivity. Modifications to the cyclic ether moiety are made to better fit the JNK3 binding pocket, thereby increasing potency and specificity.",
            "Final Target Molecule": "COC(=O)c1ccc(=O)n(CCc2ccc3c(c2)OCC3)c1"
        }
    },
    {
        "src_smiles": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCCC(O)C3)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central pyridine ring substituted with two fluorinated phenyl ether groups and a piperazine ring bearing a hydroxyl moiety. This structure provides multiple sites for hydrogen bonding and hydrophobic interactions, which are essential for JNK3 binding.",
            "Property Analysis": "The molecule demonstrates moderate inhibition of JNK3, likely due to the fluorinated phenyl groups enhancing binding affinity through hydrophobic interactions. The hydroxyl group on the piperazine may contribute to hydrogen bonding within the active site of JNK3.",
            "Limitation in Source Molecule for Property": "The piperazine ring may lead to reduced selectivity and potential off-target interactions. Additionally, the multiple fluorine substitutions could negatively impact the molecule's solubility and metabolic stability.",
            "Optimization for Source Molecule": "Replace the piperazine ring with a morpholine moiety to enhance solubility and reduce off-target interactions. Modify the fluorinated phenyl groups to optimize hydrogen bonding and hydrophobic interactions with JNK3, potentially increasing selectivity and potency.",
            "Final Target Molecule": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCCOC3)nc21"
        }
    },
    {
        "src_smiles": "O=C(Nc1ccc2c(c1)OCO2)C1CC(c2c(F)cccc2Cl)=NO1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a bicyclic structure with a fused benzofuran core linked via an amide bond. It contains a chlorinated aromatic ring and a fluorinated substituent, which may contribute to its binding affinity and metabolic stability. The presence of a nitro group could be important for electronic properties and potential interactions with the target protein.",
            "Property Analysis": "The molecule acts as an inhibitor of c-Jun N-terminal kinase 3 (JNK3), which plays a critical role in cellular stress responses and apoptosis. Effective JNK3 inhibition requires the molecule to bind with high affinity and selectivity to the enzyme's active site, potentially interacting with key amino acid residues through hydrogen bonding, hydrophobic interactions, and electronic complementarity.",
            "Limitation in Source Molecule for Property": "The current structure may lack optimal interactions with specific residues in the JNK3 active site, potentially limiting potency and selectivity. Additionally, the presence of the nitro group might affect the molecule's metabolic stability and toxicity profile. The chlorinated aromatic ring, while contributing to binding, may also hinder selectivity against other kinases with similar binding pockets.",
            "Optimization for Source Molecule": "Enhance interactions with JNK3 by modifying the aromatic substituents to improve binding affinity and selectivity. Introducing a methyl or methoxy group could enhance hydrophobic interactions within the active site. Replacing the nitro group with less toxic functional groups such as a cyano or trifluoromethyl group might improve metabolic stability. Additionally, optimizing the fluorine placement could enhance electronic interactions without compromising selectivity.",
            "Final Target Molecule": "O=C(Nc1ccc2c(c1)OCO2)C1CC(c2c(F)cccc2Cl)=NC(C)1"
        }
    },
    {
        "src_smiles": "Clc1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a chlorophenyl group attached to a 1,2,4-triazole ring, which is further connected to a 2,5-diaminopyrazine moiety. Additionally, there is a 2-(2-((diethoxy)methyl)ethyl)amino substituent attached to the aromatic system.",
            "Property Analysis": "The molecule exhibits moderate inhibition of JNK3 with reasonable selectivity. The presence of the chlorophenyl group and the triazole core are crucial for binding affinity. However, the molecule may have limited solubility and potential off-target interactions due to the chloro substituent.",
            "Limitation in Source Molecule for Property": "The chlorophenyl group may hinder solubility and contribute to off-target effects. Additionally, the lack of specific substituents to enhance hydrogen bonding or hydrophobic interactions could limit the binding affinity and selectivity towards JNK3.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, replace the chlorophenyl group with a more hydrophilic substituent such as a methoxyphenyl group to improve solubility. Introduce a methyl group on the triazole ring to increase binding affinity and selectivity. Modify the amino substituent to include a morpholine ring to enhance hydrogen bonding interactions and further improve selectivity.",
            "Final Target Molecule": "COC1=CC=C(C=C1)Nc2ncnc(NC3CCOCC3)c2Nc4cc(NC(CCOCC)OCC)nc4"
        }
    },
    {
        "src_smiles": "CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OCc3ccccc3)c2)[nH]1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a 1,2,4-triazole derivative featuring a thioether linkage connecting to a fluorophenyl group and a 2-aminopyridine moiety substituted with a methoxyphenyl ether. The presence of heteroatoms such as nitrogen and sulfur in the triazole ring may facilitate hydrogen bonding and hydrophobic interactions with biological targets.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), a protein implicated in various neurological disorders. Key features contributing to its activity include the fluorophenyl group and the methoxy-substituted aromatic rings, which likely interact with the ATP-binding site of JNK3.",
            "Limitation in Source Molecule for Property": "The source molecule may suffer from suboptimal selectivity towards JNK3 over other kinases, potentially leading to off-target effects. Additionally, metabolic stability and solubility could be concerns, affecting its bioavailability and efficacy.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications can include introducing electron-withdrawing groups to increase binding affinity, adding substituents to enhance selectivity by targeting unique residues in JNK3, and improving pharmacokinetic properties by increasing metabolic stability and solubility. For example, replacing the methoxy group with a more metabolically stable fluoromethyl group and adding a chloro substituent to the triazole ring could enhance binding specificity and potency.",
            "Final Target Molecule": "CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OC(F)C)c2)[nH]1"
        }
    },
    {
        "src_smiles": "CC(C)(C)c1cnc(CSc2cnc(NC(=O)c3ccccc3)s2)o1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a t-butyl group attached to a 1,3-diazole ring. The diazole ring is substituted with a thiocarbonyl-linked side chain containing a thiazole ring connected to a carbamate group linked to a phenyl ring. This structure provides multiple points for potential hydrogen bonding and hydrophobic interactions.",
            "Property Analysis": "The molecule exhibits potential as a JNK3 inhibitor due to its ability to interact with the ATP-binding site of the kinase. The presence of the carbamate and thiazole groups may facilitate key interactions necessary for inhibition. However, the bulky t-butyl group may hinder optimal binding efficiency.",
            "Limitation in Source Molecule for Property": "The t-butyl group introduces steric bulk that may reduce binding affinity and selectivity towards JNK3. Additionally, the molecule may have suboptimal solubility and metabolic stability, limiting its efficacy and bioavailability.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, the bulky t-butyl group can be replaced with a smaller alkyl or fluorinated substituent to reduce steric hindrance and improve binding affinity. Introducing a hydrogen bond donor or acceptor in the side chain can strengthen interactions with the kinase. Modifying the carbamate linkage to a more metabolically stable moiety can enhance the molecule's stability and bioavailability.",
            "Final Target Molecule": "CC(F)c1cnc(CSc2cnc(NC(=O)c3ccccc3)s2)o1"
        }
    },
    {
        "src_smiles": "COc1cc2ncnc(N3CCN(C(=O)Nc4ccccn4)CC3)c2cc1OC",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a methoxy-substituted naphthalene core connected to a triazole ring. The triazole is further linked to a piperazine ring, which is attached to a carbamoyl-aniline moiety. This structure provides multiple points for potential interactions with biological targets, including hydrogen bond donors and acceptors, as well as aromatic systems for \u03c0-stacking interactions.",
            "Property Analysis": "The molecule exhibits moderate inhibition of c-Jun N-terminal kinase 3 (JNK3) with an IC\u2085\u2080 in the low micromolar range. Its selectivity profile indicates some off-target activity against other kinases, which may limit its therapeutic applicability. Additionally, the molecule displays reasonable cell permeability but suboptimal solubility.",
            "Limitation in Source Molecule for Property": "The primary limitations include insufficient potency against JNK3, likely due to suboptimal binding interactions within the kinase's active site. Additionally, the presence of electron-donating methoxy groups may reduce binding affinity, and the piperazine linker could be metabolically unstable, leading to rapid degradation.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce electron-withdrawing groups such as fluorine or trifluoromethyl at strategic positions on the naphthalene core to strengthen binding interactions. Replace the methoxy groups with more polar substituents like hydroxyl or amino groups to form additional hydrogen bonds. Modify the piperazine linker by incorporating a more metabolically stable moiety, such as a morpholine ring, to improve the molecule's overall stability and bioavailability.",
            "Final Target Molecule": "COc1cc2ncnc(N3CCO(C(=O)Nc4ccccn4)CC3)c2cc1F"
        }
    },
    {
        "src_smiles": "CCCC(=O)Nc1nc(NCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, CCCC(=O)Nc1nc(NCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1, consists of a butanoyl linker attached to a heterocyclic core. The core contains a pyrimidine ring substituted with an N,N-diisopropylamino group and a methoxy-substituted phenyl ring. The molecule features hydrogen bond donors and acceptors, as well as hydrophobic regions derived from the alkyl chains and aromatic rings.",
            "Property Analysis": "The molecule exhibits potential as a JNK3 inhibitor due to the presence of hydrogen bonding sites that can interact with the kinase's active site. The hydrophobic aromatic rings may facilitate binding through hydrophobic interactions. The overall structure suggests moderate aqueous solubility, which is favorable for bioavailability.",
            "Limitation in Source Molecule for Property": "The current molecule may have limited selectivity towards JNK3 over other kinases due to the presence of non-specific hydrophobic regions. Additionally, the diisopropylamino group may contribute to poor metabolic stability and membrane permeability issues. The butanoyl linker could introduce flexibility that reduces binding affinity.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications can be made to increase selectivity and binding affinity. Introducing electron-withdrawing groups on the phenyl ring may strengthen hydrogen bonding interactions. Reducing the size of the N,N-diisopropylamino group to a smaller amino substituent could improve metabolic stability. Replacing the butanoyl linker with a more rigid moiety may reduce conformational flexibility, enhancing binding specificity.",
            "Final Target Molecule": "CC(=O)Nc1nc(NC(C)C)c2ccc(OC)cc2n2ncn(C)c2n1"
        }
    },
    {
        "src_smiles": "COc1ccc(-n2c(=O)c(C)nc3cnc(N4CCNCC4)nc32)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a methoxy-substituted benzene ring linked to a complex heterocyclic structure. Specifically, it contains a pyrimidine core fused with a triazine ring, incorporating a carbonyl group and a piperazine moiety. The presence of the nitrogen atoms in the heterocycles suggests potential hydrogen bonding sites, which are crucial for binding interactions with the JNK3 enzyme.",
            "Property Analysis": "The molecule acts as an inhibitor of c-Jun N-terminal kinase 3 (JNK3), a protein involved in various cellular processes including inflammation and apoptosis. The methoxy group enhances the compound's lipophilicity, potentially improving cell membrane permeability. The piperazine ring may contribute to solubility and offer flexibility for binding within the enzyme's active site.",
            "Limitation in Source Molecule for Property": "The current structure may exhibit limited selectivity towards JNK3 over other kinases, leading to potential off-target effects. Additionally, the molecule's high lipophilicity might result in poor aqueous solubility and unfavorable pharmacokinetic properties. The methoxy group could also be susceptible to metabolic demethylation, reducing the compound's stability and efficacy.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications can be made to improve selectivity and metabolic stability. Introducing electron-withdrawing groups, such as a fluorine atom, to the benzene ring could increase binding affinity and selectivity. Replacing the methoxy group with a more metabolically stable substituent like a trifluoromethyl group may enhance the compound's stability. Additionally, modifying the piperazine ring to include additional hydrogen bond donors or acceptors could strengthen interactions with the JNK3 active site.",
            "Final Target Molecule": "COc1ccc(-n2c(=O)c(C)nc3c(F)nc(N4CCNCC4)nc32)cc1"
        }
    },
    {
        "src_smiles": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCC(O)C3)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a triazolopyridone derivative featuring a central pyridine ring substituted with a 4-fluoro-phenyl ether moiety and a piperidine ring containing a hydroxyl group. The molecule includes a dimethylamine group attached to the triazole ring, which may play a role in its biological activity.",
            "Property Analysis": "The compound exhibits potential inhibitory activity against c-Jun N-terminal kinase 3 (JNK3) based on its structural features, such as the presence of electron-withdrawing fluorine atoms which may enhance binding affinity. The hydroxyl group could contribute to hydrogen bonding interactions with the kinase active site, potentially increasing selectivity and potency.",
            "Limitation in Source Molecule for Property": "The source molecule may suffer from limited selectivity towards JNK3 due to the presence of similar kinase binding motifs, potentially leading to off-target effects. Additionally, the molecule's polarity from multiple hydroxyl and amine groups might affect its cell permeability and bioavailability, limiting its effectiveness as a therapeutic agent.",
            "Optimization for Source Molecule": "To enhance JNK3 selectivity and improve pharmacokinetic properties, modifications could include reducing molecular polarity by methylating the hydroxyl group, introducing bulkier substituents to increase binding specificity, and optimizing the electronic properties of the aromatic rings to strengthen interactions with the JNK3 active site. Introducing a metabolic stable linker or replacing vulnerable moieties could also enhance bioavailability and reduce degradation.",
            "Final Target Molecule": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CC(C)C3)nc21"
        }
    },
    {
        "src_smiles": "COc1ccc(-n2c(=O)cnc3cnc(Oc4cccc(Cl)c4)nc32)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central benzene ring substituted with a methoxy group and a nitrogen-containing heterocyclic moiety. The heterocycle includes fused pyrimidine and imidazole rings, further substituted with a chloro-substituted phenyl ether. The presence of multiple nitrogen atoms and electron-donating/-withdrawing groups suggests potential interactions with the JNK3 kinase active site.",
            "Property Analysis": "The source molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), a key enzyme involved in various cellular processes. Effective JNK3 inhibitors typically form hydrogen bonds and hydrophobic interactions within the kinase's active site, thereby preventing phosphorylation of target substrates.",
            "Limitation in Source Molecule for Property": "Despite its inhibitory activity, the source molecule may suffer from suboptimal binding affinity due to limited hydrophobic interactions and potential steric hindrance from bulky substituents. Additionally, the methoxy group may reduce metabolic stability, and the presence of multiple nitrogen atoms could affect selectivity and solubility.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications can be made to increase binding affinity and selectivity. Introducing a more hydrophobic substituent in place of the methoxy group could improve hydrophobic interactions with the kinase. Reducing steric bulk around the heterocyclic core may alleviate potential hindrance. Furthermore, replacing the chloro-substituted phenyl ether with a fluorinated analog might enhance metabolic stability and selectivity towards JNK3.",
            "Final Target Molecule": "COc1ccc(-n2c(=O)cnc3cnc(Oc4ccc(F)cc4)nc32)cc1."
        }
    },
    {
        "src_smiles": "CCNCCC(=O)Nc1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a piperazine linker connected to an amide bond, a 1,2,4-triazole core substituted with a methyl group, and a fused aromatic system with a fluorophenyl group. The presence of multiple nitrogen atoms may facilitate hydrogen bonding interactions with the JNK3 kinase.",
            "Property Analysis": "The molecule acts as an inhibitor of c-Jun N-terminal kinase 3 (JNK3), potentially interfering with its ATP binding site. Key properties include binding affinity, selectivity towards JNK3 over other kinases, and favorable pharmacokinetic profiles.",
            "Limitation in Source Molecule for Property": "The current structure may exhibit limited selectivity towards JNK3 due to similar binding sites in other kinases. Additionally, the molecule may have suboptimal pharmacokinetic properties, such as poor solubility or metabolic stability.",
            "Optimization for Source Molecule": "Introduce substituents on the aromatic rings to enhance selective interactions with JNK3. Modify the piperazine linker to improve binding affinity and selectivity. Incorporate electron-withdrawing groups to increase metabolic stability and solubility. Optimize the triazole core for better hydrogen bonding and fit within the ATP binding pocket.",
            "Final Target Molecule": "CCNCCN(C)C(=O)Nc1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C(F)C"
        }
    },
    {
        "src_smiles": "NC1=NC(CF)(c2cc(Oc3ncccn3)ccc2F)CC(C(F)(F)F)O1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a substituted benzimidazole featuring a trifluoromethyl group, a methoxy-substituted phenyl ring with an additional fluorine atom, and a geminal trifluoromethyl alcohol group. The presence of multiple fluorine atoms contributes to the molecule's lipophilicity and metabolic stability.",
            "Property Analysis": "The molecule exhibits inhibitory activity against JNK3 due to its ability to form key hydrophobic and hydrogen-bonding interactions within the kinase's active site. The trifluoromethyl groups enhance binding affinity and metabolic resistance, while the methoxy and fluorophenyl substitutions contribute to selectivity.",
            "Limitation in Source Molecule for Property": "Despite its inhibitory activity, the source molecule may suffer from limited selectivity against other kinases due to similar binding site features. Additionally, the high lipophilicity from multiple fluorine atoms could lead to poor solubility and bioavailability.",
            "Optimization for Source Molecule": "To enhance JNK3 selectivity and improve pharmacokinetic properties, introduce a polar substituent to increase solubility, replace some fluorine atoms with groups that can form specific interactions with JNK3, and reduce overall lipophilicity to improve bioavailability.",
            "Final Target Molecule": "NC1=NC(CF)(c2cc(Oc3ncccn3)ccc2F)CC(C(F)(O)F)O1"
        }
    },
    {
        "src_smiles": "Oc1ccc(Nc2nc(-c3ccc(N4CCOCC4)cc3)cs2)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a phenolic hydroxyl group attached to a benzene ring, which is further substituted with an amide-linked thiazole ring. The thiazole is connected to a substituted aromatic ring bearing a piperazine ether moiety. The presence of multiple nitrogen and sulfur heteroatoms suggests potential for hydrogen bonding and hydrophobic interactions with biological targets.",
            "Property Analysis": "The molecule acts as a moderate inhibitor of c-Jun N-terminal kinase 3 (JNK3). Its inhibitory activity is likely mediated through interactions between the heterocyclic cores and the active site of JNK3, but there is room for improvement in terms of binding affinity and selectivity.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from suboptimal binding affinity due to limited interactions within the JNK3 active site. Additionally, the flexible ether linkage and the absence of specific functional groups necessary for strong, selective binding may reduce both potency and selectivity against other kinases.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce a more rigid linker in place of the flexible ether to reduce conformational entropy loss upon binding. Incorporate additional hydrogen bond donors or acceptors to form stronger interactions with key residues in the JNK3 active site. Modify the aromatic substitution to include electron-withdrawing groups to increase binding affinity and improve selectivity.",
            "Final Target Molecule": "Oc1ccc(Nc2nc(-c3cc(F)cc(F)c3)cs2)cc1"
        }
    },
    {
        "src_smiles": "O=c1cnc2cnc(OCc3ccccc3)nc2n1Cc1ccc(F)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a central pyrimidine core with multiple nitrogen atoms, facilitating potential hydrogen bonding interactions. It includes a methoxy-substituted phenyl ring and a fluorophenyl group, which may enhance \u03c0-\u03c0 stacking interactions and lipophilicity. The ketone functional group acts as a hydrogen bond acceptor, potentially increasing binding affinity to JNK3's active site.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), a kinase involved in regulating apoptosis and inflammation. The electron-withdrawing fluorophenyl moiety may improve binding affinity through favorable interactions within JNK3's active site. However, the current potency and selectivity may be moderate, indicating room for enhancement through structural optimization.",
            "Limitation in Source Molecule for Property": "The source molecule may have limited selectivity for JNK3 over other kinases, risking off-target effects. Its high lipophilicity could result in poor solubility and bioavailability. Additionally, the existing functional groups might not fully exploit all key interactions within JNK3's active site, potentially limiting binding strength and inhibitory efficacy.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, the molecule can be modified to enhance selectivity and binding affinity. Introducing additional hydrogen bond donors or acceptors could strengthen interactions with JNK3's active site. Modifying the methoxy group to a more polar substituent may increase solubility. Exploring different substituents on the phenyl rings could aid in optimizing \u03c0-\u03c0 stacking and hydrophobic interactions. Rigidifying the molecular structure might also improve binding orientation and potency.",
            "Final Target Molecule": "O=C1CN=C2CN=C(OCC3ccc(CF)cc3)NC2N1Cc1cc(O)cc(F)c1"
        }
    },
    {
        "src_smiles": "O=C(CSc1nc2ccccc2c(=O)n1CCCO)NCc1ccccc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a carbamate linker connecting a thiourea-substituted pyridine moiety with a phenylethylamine group. It features multiple aromatic rings, a thioether linkage, and an ethanolamine side chain, which may facilitate interactions through hydrogen bonding and hydrophobic pockets in the JNK3 binding site.",
            "Property Analysis": "The molecule has moderate molecular weight and displays a balance of hydrophobic and hydrophilic regions, which are favorable for enzyme inhibition. However, the presence of multiple aromatic systems and flexible linkers may affect solubility and selectivity towards JNK3.",
            "Limitation in Source Molecule for Property": "The thioether linkage is prone to metabolic oxidation, potentially reducing the molecule's stability and bioavailability. Additionally, the extensive aromatic system may lead to off-target interactions, decreasing selectivity for JNK3.",
            "Optimization for Source Molecule": "Replace the thioether linkage with a more metabolically stable amide bond to enhance stability. Introduce polar substituents to improve solubility without compromising binding affinity. Modify the aromatic rings to increase planarity and specificity towards JNK3 by adding substituents that can form additional hydrogen bonds or pi-stacking interactions with the kinase active site.",
            "Final Target Molecule": "O=C(CC(NCc1ccccc1)NCc2nc3ccccc3c(=O)n2CCCO)Nc4ccccc4"
        }
    },
    {
        "src_smiles": "CCC(C)(C)Nc1c(C#N)cnc2cnc(NCc3cccnc3)cc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central tertiary butyl amine connected to a fused triazole-pyrimidine ring system. It contains a nitrile group attached to the triazole ring and an aniline-like moiety linked through a methylene spacer to a substituted triazole.",
            "Property Analysis": "The molecule acts as an inhibitor of c-Jun N-terminal kinase 3 (JNK3), likely through interactions with the kinase's active site. Key features contributing to its activity include the triazole-pyrimidine core, which may form hydrogen bonds and \u03c0-\u03c0 interactions with the enzyme, and the nitrile group, which can act as a hydrogen bond acceptor.",
            "Limitation in Source Molecule for Property": "The source molecule may suffer from limited solubility and suboptimal binding affinity due to steric hindrance from the bulky tert-butyl group. Additionally, the presence of a nitrile group could limit hydrogen bonding capabilities, potentially reducing binding interactions with JNK3.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibitory activity, replace the bulky tert-butyl group with a less sterically demanding substituent to improve binding affinity. Introduce polar functional groups to increase solubility and facilitate additional hydrogen bonding interactions. Modify the nitrile group to a more versatile hydrogen bond acceptor or donor to enhance interactions within the kinase active site.",
            "Final Target Molecule": "CCN(C)c1c(C=O)cnc2cnc(NCc3cccnc3)cc12"
        }
    },
    {
        "src_smiles": "O=C1SC(=Cc2ccc3cc(F)ccc3n2)C(=O)N1CCN1CCCCC1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a thiourea core connected to a benzyl group substituted with a fluorine atom. It features a bicyclic structure with a piperidine ring linked to a benzothiadiazole moiety, incorporating both carbonyl and sulfur functional groups.",
            "Property Analysis": "The molecule exhibits JNK3 inhibitory activity, likely through interactions with the ATP-binding site of the kinase. The presence of fluorine may enhance binding affinity and metabolic stability. The overall structure provides multiple hydrogen bond donors and acceptors, facilitating strong interactions with the target protein.",
            "Limitation in Source Molecule for Property": "Limited selectivity towards JNK3 over other kinases due to the conserved nature of the ATP-binding site. Additionally, the molecule may have suboptimal pharmacokinetic properties, such as solubility and membrane permeability, which could affect its bioavailability and efficacy.",
            "Optimization for Source Molecule": "Introduce substituents that enhance selectivity by exploiting unique binding pockets of JNK3. Modify the thiourea linkage to improve metabolic stability and reduce off-target interactions. Enhance solubility by adding polar functional groups without compromising binding affinity. Consider adding a heteroaryl moiety to increase interactions with specific residues in the JNK3 active site.",
            "Final Target Molecule": "O=C1SC(=Cc2ccc3cc(F)ccc3n2)C(=O)N1CCN1CCCCC1N(C)C"
        }
    },
    {
        "src_smiles": "CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(NC3CCCNC3)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central triazole ring fused to a bipyrimidine scaffold. It contains a chloro-substituted aromatic amine and a piperazine moiety, which may interact with the JNK3 binding site through hydrogen bonding and hydrophobic interactions.",
            "Property Analysis": "The molecule exhibits moderate inhibition of JNK3 with potential selectivity due to the presence of multiple nitrogen atoms facilitating specific interactions. However, the chloro group may contribute to off-target effects and metabolic instability.",
            "Limitation in Source Molecule for Property": "The chloro substituent may reduce metabolic stability and increase toxicity. Additionally, the piperazine ring could lead to poor pharmacokinetic properties and non-selective binding with other kinases.",
            "Optimization for Source Molecule": "Remove or replace the chloro group with a more metabolically stable substituent such as a trifluoromethyl group to enhance stability and selectivity. Modify the piperazine moiety to a more rigid structure to improve binding specificity and pharmacokinetic profiles.",
            "Final Target Molecule": "CC(C)n1cnc2c(Nc3cc(C(F)(F)F)cc(N)c3)nc(NC3CCCN3)nc21"
        }
    },
    {
        "src_smiles": "NC(=O)c1cccc2c(NCc3cccc(Nc4nccs4)c3)ncnc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises an amide linkage attached to a fused ring system containing triazole and thiazole rings. It features multiple aromatic rings and nitrogen heteroatoms, which may facilitate interactions with the JNK3 kinase active site.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), likely through binding interactions mediated by its heterocyclic and aromatic structures. The presence of hydrogen bond donors and acceptors contributes to its binding affinity.",
            "Limitation in Source Molecule for Property": "The source molecule may have limited selectivity for JNK3 over other kinases, potential issues with bioavailability, and suboptimal pharmacokinetic properties such as solubility and metabolic stability.",
            "Optimization for Source Molecule": "Introduce substituents to enhance binding affinity and selectivity for JNK3 by forming additional hydrogen bonds or hydrophobic interactions. Modify the thiazole ring to improve specificity and add polar groups to increase solubility and metabolic stability.",
            "Final Target Molecule": "NC(=O)c1cccc2c(NCc3cccc(Nc4nccs4C)c3)ncnc12"
        }
    },
    {
        "src_smiles": "COc1ccc(OC)c(C2=NOC(C(=O)Nc3cccc(C(C)=O)c3)C2)c1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a di-methoxyphenyl core connected to a complex heterocyclic system. It features an ether linkage between two aromatic rings, an oxadiazole ring, and multiple amide functionalities. Additionally, there are acetyl groups attached to the aromatic rings, contributing to the overall molecular complexity and hydrogen bonding potential.",
            "Property Analysis": "The molecule exhibits potential inhibitory activity against JNK3 (c-Jun N-terminal kinase 3) due to its multiple hydrogen bond donors and acceptors, which can interact with the active site of the kinase. The presence of aromatic rings facilitates \u03c0-\u03c0 interactions, while the heterocyclic components may contribute to binding specificity and potency.",
            "Limitation in Source Molecule for Property": "Despite its promising features, the source molecule may suffer from limited selectivity towards JNK3 over other kinases, potentially leading to off-target effects. Additionally, the multiple methoxy and acetyl groups may reduce the molecule's bioavailability and metabolic stability, hindering its effectiveness as a therapeutic agent.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modifications could include introducing substituents that increase binding affinity and selectivity for JNK3. Reducing the number of methoxy and acetyl groups may improve bioavailability and metabolic stability. Incorporating heterocycles that are known to interact favorably with JNK3's active site could further optimize the molecule. Additionally, enhancing the rigidity of the molecular framework may improve binding specificity.",
            "Final Target Molecule": "COc1ccccc1C2=NOC(C(=O)Nc3ccccc3)C2"
        }
    },
    {
        "src_smiles": "CC1CC(C)CN(S(=O)(=O)c2ccc(C(=O)NCc3ccco3)cc2)C1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a cyclohexylamine core substituted with a sulfonyl group linked to a phenyl ring bearing an amide-functionalized triazole moiety. The presence of the cyclohexyl group provides conformational rigidity, while the sulfonyl and amide functionalities offer hydrogen bonding opportunities, which are crucial for biological interactions.",
            "Property Analysis": "The molecule exhibits moderate inhibition of JNK3 (c-Jun N-terminal kinase 3) with an IC50 in the low micromolar range. The sulfonylphenyl group interacts with the ATP-binding pocket of JNK3, while the triazole ring contributes to binding affinity through pi-stacking interactions.",
            "Limitation in Source Molecule for Property": "The current compound shows limited selectivity towards JNK3 over other kinases, potentially leading to off-target effects. Additionally, the metabolic stability is suboptimal due to the presence of the amide bond, which is susceptible to hydrolysis.",
            "Optimization for Source Molecule": "Introduce bulkier and more selective substituents on the phenyl ring to enhance selectivity towards JNK3. Replace the amide bond with a more metabolically stable bioisostere such as a sulfonamide. Modify the cyclohexyl ring to a more rigid scaffold to improve binding affinity and reduce conformational flexibility.",
            "Final Target Molecule": "CC1CC(C)CN(S(=O)(=O)c2ccc(C(=O)NS(=O)(=O)c3ccco3)cc2)C1"
        }
    },
    {
        "src_smiles": "COC(=O)c1ccc(-c2ccc(C=C3SC(=O)NC3=O)o2)c(O)c1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains an ester functional group (COC(=O)), a benzene ring substituted with a hydroxyl group (-c(O)), and a complex side chain involving a thiophene ring fused to a sulfonamide moiety (-C=C3SC(=O)NC3=O) connected via a dihydroxylated benzene ring.",
            "Property Analysis": "The molecule exhibits potential inhibitory activity against JNK3 (c-Jun N-terminal kinase 3) due to the presence of hydrogen bond donors and acceptors, aromatic rings facilitating \u03c0-\u03c0 interactions, and hydrophobic regions that may interact with the kinase's active site.",
            "Limitation in Source Molecule for Property": "The current molecule may suffer from suboptimal binding affinity and selectivity towards JNK3. The presence of multiple hydroxyl groups can lead to poor cell permeability and metabolic instability. Additionally, the ester group may be prone to hydrolysis, reducing the molecule's stability.",
            "Optimization for Source Molecule": "Introduce fluorine substituents to enhance metabolic stability and binding affinity. Replace the ester group with a more stable amide linkage to prevent hydrolysis. Modify the thiophene ring to a more rigid heterocycle to improve selectivity. Reduce the number of hydroxyl groups to enhance cell permeability while maintaining necessary hydrogen bonding interactions.",
            "Final Target Molecule": "COC(=O)c1ccc(-c2ccc(C=C3S(C)(=O)NC3=O)F)o2)c(O)c1"
        }
    },
    {
        "src_smiles": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCC(O)C3)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a pyrazolone core substituted with two fluorinated phenyl rings and a piperazine ring bearing a hydroxyl group. The fluorine atoms contribute to increased metabolic stability and lipophilicity, while the piperazine moiety can engage in hydrogen bonding with the target kinase.",
            "Property Analysis": "The molecule exhibits potential JNK3 inhibitory activity through hydrogen bonding and hydrophobic interactions provided by the hydroxyl group and fluorophenyl rings. The structural elements promote binding affinity and membrane permeability essential for effective kinase inhibition.",
            "Limitation in Source Molecule for Property": "The presence of the hydroxyl group on the piperazine ring may lead to metabolic instability and reduced selectivity, potentially causing off-target effects. Additionally, the existing substituents may not fully exploit all binding interactions within the JNK3 active site, limiting inhibitory potency.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, the hydroxyl group on the piperazine ring should be modified to reduce metabolic liabilities, such as by methylation to form a methoxy group. Enhancing specificity can be achieved by introducing additional substituents that engage unique residues within the JNK3 active site, thereby increasing binding affinity and selectivity.",
            "Final Target Molecule": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCCO3)nc21"
        }
    },
    {
        "src_smiles": "N#Cc1cc2cnc(NCc3ccccc3)nc2n(C2CCCC2)c1=O",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a nitrile group connected to a benzene ring, fused with a pyrimidine-like heterocycle. It also has a piperidine ring and a phenyl substituent linked via an ethyl chain. The presence of multiple nitrogen atoms suggests potential hydrogen bonding interactions.",
            "Property Analysis": "The molecule exhibits potential JNK3 inhibitory activity due to its ability to interact with the kinase active site through hydrogen bonds and hydrophobic interactions. The nitrile group may act as a bioisostere for carbonyl groups, enhancing binding affinity.",
            "Limitation in Source Molecule for Property": "The molecule may suffer from limited solubility and metabolic stability due to the presence of the nitrile group and the bulky piperidine ring, which could affect its bioavailability and pharmacokinetic profile.",
            "Optimization for Source Molecule": "Introduce polar functional groups to enhance solubility, replace the nitrile group with a bioisosteric moiety to improve metabolic stability, and reduce steric bulk around the piperidine ring to enhance binding affinity and selectivity for JNK3.",
            "Final Target Molecule": "N#Cc1cc2cnc(NCc3ccccc3)nc2n(CN2CCO2)c1=O"
        }
    },
    {
        "src_smiles": "CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an isopropylamine linked to an ethanol chain, connected to a triazole ring substituted with a 4-chlorophenyl group and two isopropylmethyl groups on the triazole nitrogen atoms. The presence of the triazole ring and the chlorophenyl moiety suggests potential interactions with kinase binding sites.",
            "Property Analysis": "The molecule exhibits potential as a JNK3 inhibitor due to its triazole core, which can form hydrogen bonds with the kinase hinge region. The chlorophenyl group may engage in hydrophobic interactions within the JNK3 active site, contributing to binding affinity.",
            "Limitation in Source Molecule for Property": "The current structure may lack optimal selectivity and potency for JNK3 inhibition. Additionally, the isopropylmethyl groups on the triazole nitrogen could introduce steric hindrance, potentially reducing binding efficiency and specificity towards JNK3.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, modify the triazole substituents by replacing the isopropylmethyl groups with smaller methyl groups to reduce steric hindrance. Introduce a methoxy group on the chlorophenyl ring to increase hydrogen bonding interactions and improve binding affinity. Additionally, extend the ethanol chain to form additional hydrogen bonds within the JNK3 active site.",
            "Final Target Molecule": "CC(C)N(CCOO)c1nc(Nc2c(OC)ccc(Cl)c2)c2ncn(C)c2n1"
        }
    },
    {
        "src_smiles": "NC(=O)c1cccc2c(NCc3cccc(Nc4ncccn4)c3)ncnc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a central bicyclic core composed of fused aromatic rings, including a pyrimidine-like structure. It contains multiple nitrogen atoms within the heterocyclic rings, an amide linkage (NC(=O)), and side chains connecting to additional aromatic and triazole rings. The presence of these functional groups suggests potential sites for hydrogen bonding and pi-stacking interactions, which are crucial for kinase inhibition.",
            "Property Analysis": "The molecule acts as a JNK3 inhibitor, likely interacting with the ATP-binding pocket of the kinase. The aromatic systems facilitate pi-pi interactions, enhancing binding affinity. The amide and triazole groups provide hydrogen bond donors and acceptors, contributing to selective binding. However, the molecule's overall rigidity may limit its adaptability to the kinase active site.",
            "Limitation in Source Molecule for Property": "The source molecule may suffer from limited selectivity towards JNK3 over other kinases, increasing the risk of off-target effects. Additionally, the high degree of aromaticity could lead to poor solubility and unfavorable pharmacokinetic properties. The rigid fused ring system may restrict necessary conformational flexibility for optimal binding.",
            "Optimization for Source Molecule": "To enhance JNK3 selectivity and binding affinity, introduce substituents that can form additional hydrogen bonds or ionic interactions specific to JNK3's active site. Modifying the amide linkage to a more flexible or bioavailable moiety could improve binding dynamics. Reducing aromaticity by incorporating heteroatoms may enhance solubility. Additionally, altering the fused ring system to introduce conformational flexibility can allow better accommodation within the kinase binding pocket.",
            "Final Target Molecule": "NC(=O)c1ccc2c(NCc3ccccc3N)c(Nc4ncccn4)c1n2"
        }
    },
    {
        "src_smiles": "CNc1cc(N(CCCN(C)C)C(=O)Nc2c(Cl)cccc2Cl)ncn1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a pyridine ring substituted with a methylamino group at one position and a complex side chain. The side chain includes a propyl linker connected to a tertiary amine and a benzamide moiety with two chlorine atoms on the aromatic ring. The molecule features multiple nitrogen and chlorine atoms, contributing to its potential binding interactions.",
            "Property Analysis": "The molecule is designed to inhibit JNK3 (c-Jun N-terminal kinase 3), a target implicated in various neurological disorders. Key properties for effective JNK3 inhibition include high binding affinity, selectivity over other kinases, appropriate molecular weight, and favorable pharmacokinetic properties such as solubility and metabolic stability.",
            "Limitation in Source Molecule for Property": "The source molecule may exhibit limited selectivity due to the presence of multiple potential binding sites, which could lead to off-target effects. Additionally, the molecule's lipophilicity from multiple aromatic and chlorinated groups may affect its solubility and bioavailability. The current substituents may not optimize interactions necessary for high-affinity binding to the JNK3 active site.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, structural modifications could include introducing more specific hydrogen bond donors or acceptors to improve binding affinity and selectivity. Reducing lipophilicity by modifying or replacing chlorinated aromatic rings can improve solubility and pharmacokinetic properties. Incorporating a more rigid linker may enhance the molecule's ability to fit precisely into the JNK3 active site, thereby increasing selectivity and potency.",
            "Final Target Molecule": "CNc1cc(N(CCCOC(C)C)C(=O)Nc2c(Cl)cc(Cl)c2Cl)ncn1"
        }
    },
    {
        "src_smiles": "CCCCNC(=O)Cc1c(OC)ccc2cc(Br)ccc12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, CCCCNC(=O)Cc1c(OC)ccc2cc(Br)ccc12, consists of a butyl chain linked to an amide group, connected to a benzopyridine core. The benzopyridine core is substituted with a methoxy group and a bromine atom, forming a tricyclic structure that is likely critical for its interaction with the JNK3 enzyme.",
            "Property Analysis": "The molecule exhibits potential JNK3 inhibitory activity through its benzopyridine core, which may interact with the ATP-binding site of the kinase. The presence of the bromine atom could enhance binding affinity through halogen bonding. However, the molecule's lipophilicity and potential metabolic liabilities may affect its drug-like properties and bioavailability.",
            "Limitation in Source Molecule for Property": "The presence of the bromine atom, while beneficial for binding affinity, may pose metabolic stability issues and affect the compound's overall selectivity. Additionally, the amide linkage might be susceptible to hydrolysis, potentially reducing the molecule's stability in biological systems.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, the bromine atom can be replaced with a fluorine to maintain halogen bonding while enhancing metabolic stability. Introducing a methyl group on the benzopyridine core could increase hydrophobic interactions, potentially boosting binding affinity. Additionally, replacing the amide linkage with a more stable urea moiety could enhance the molecule's metabolic stability and overall bioavailability.",
            "Final Target Molecule": "CCCCNC(=O)Cc1c(OC)ccc2cc(F)ccc12"
        }
    },
    {
        "src_smiles": "C#Cc1cc(Oc2cnc(NCC(C)O)nc2N)c(C(C)C)cc1OC",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a propiolic acid moiety (C#C) attached to a substituted benzene ring. The benzene ring is further substituted with methoxy groups and an imidazole derivative linked via an ether bond. Additionally, there is a side chain featuring an amino alcohol functionality, which may facilitate hydrogen bonding with the target enzyme.",
            "Property Analysis": "The molecule exhibits potential inhibitory activity against JNK3, primarily through interactions mediated by the imidazole ring and hydroxyl groups that can form hydrogen bonds and engage in specific binding within the active site of JNK3.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from limited selectivity and potency towards JNK3 due to the presence of multiple methoxy groups, which could lead to off-target interactions. Additionally, the propiolic acid moiety may contribute to metabolic instability, reducing the molecule's overall efficacy.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibitory properties, introduce bulkier hydrophobic substituents to improve binding affinity and selectivity. Replace methoxy groups with more selective substituents to reduce off-target effects. Modify the propiolic acid moiety to a more metabolically stable bioisostere and optimize the linker length to ensure a better fit within the JNK3 active site.",
            "Final Target Molecule": "C#Cc1c(C)cc(Oc2cnc(NCC(C)O)nc2N)c(C(C)C)cc1OC"
        }
    },
    {
        "src_smiles": "OC1CCCC(c2nccnc2Oc2ccc(Nc3ccccn3)cc2)C1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a cyclopentanol core substituted with a pyrimidine ring connected via an ether linkage to a phenyl ring bearing a 2-aminopyridine moiety. This structure includes multiple aromatic systems, nitrogen-containing heterocycles, an alcohol group, and ether linkages, which may facilitate various interactions with the JNK3 kinase active site.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), potentially through hydrogen bonding and hydrophobic interactions provided by its aromatic and heterocyclic components. The presence of multiple nitrogen atoms may enable favorable binding interactions within the kinase's ATP-binding pocket.",
            "Limitation in Source Molecule for Property": "The source molecule may suffer from limited specificity and binding affinity towards JNK3 due to the absence of additional hydrogen bond donors/acceptors and optimal hydrophobic interactions. Its flexible cyclopentanol core may reduce binding rigidity, potentially leading to lower potency and selectivity.",
            "Optimization for Source Molecule": "Enhance JNK3 inhibition by introducing substituents that increase hydrogen bonding capability and hydrophobic interactions within the kinase's active site. Rigidify the molecular structure to improve binding affinity and selectivity. For example, replacing the cyclopentanol ring with a more rigid cyclohexyl or bicyclic system and adding electron-donating groups to the phenyl ring could strengthen interactions with JNK3.",
            "Final Target Molecule": "OC1CCCCC1(c2nccnc2Oc2ccc(Nc3ccccn3)cc2)C1"
        }
    },
    {
        "src_smiles": "CC(C)C(CO)Nc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, CC(C)C(CO)Nc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1, consists of a central triazole ring fused to a pyrimidine ring. It has a diisopropylaminoethyl side chain attached to the triazole ring and a 4-hydroxylphenyl group linked through a carbonyl moiety. The molecule features multiple nitrogen atoms, which can act as hydrogen bond donors or acceptors, and a hydroxyl group that may engage in hydrogen bonding interactions.",
            "Property Analysis": "The molecule exhibits moderate polarity due to the presence of hydroxyl and amino groups, which can facilitate solubility in aqueous environments. The aromatic rings and triazole structure provide planar regions that may engage in \u03c0-\u03c0 stacking interactions with the JNK3 active site. The molecular weight is within a range suitable for kinase inhibitors, and the presence of multiple hydrogen bond donors and acceptors suggests potential for strong binding affinity to the kinase domain.",
            "Limitation in Source Molecule for Property": "While the source molecule has functional groups capable of interacting with JNK3, its selectivity may be limited due to the presence of multiple hydrogen bond donors and acceptors, which could lead to off-target interactions with other kinases. Additionally, the flexibility of the side chain might reduce binding specificity, and the lack of bulky substituents may result in lower binding affinity and selectivity for the JNK3 active site.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, the molecule can be modified to increase selectivity and binding affinity. Introducing substituents that enhance hydrophobic interactions within the JNK3 active site can improve specificity. Adding steric bulk to occupy unique pockets in JNK3 can prevent binding to other kinases. Modifying the aminoethyl side chain to rigidify its conformation may reduce entropy loss upon binding, thereby increasing affinity. Additionally, replacing the hydroxyl group with a more favorable hydrogen bond acceptor could strengthen interactions with specific amino acids in the JNK3 binding pocket.",
            "Final Target Molecule": "CC(C)C(CO)Nc1nc(NCc2ccccc2OCC)c2ncn(C(C)C)c2n1"
        }
    },
    {
        "src_smiles": "Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a bicyclic core with nitrogen heteroatoms, connected to a phenyl ring substituted with an amide linkage and a fluorinated phenyl group. The presence of nitrogen atoms suggests potential hydrogen bonding capabilities, while the fluorine atom may enhance metabolic stability and lipophilicity.",
            "Property Analysis": "The molecule exhibits inhibitory activity against JNK3 through interactions facilitated by its amide and fluorinated phenyl groups. These functional groups likely contribute to binding affinity and selectivity towards the JNK3 active site. However, the overall potency may be limited by the molecule's solubility and cell permeability.",
            "Limitation in Source Molecule for Property": "The source molecule may have suboptimal selectivity over other kinases, potentially leading to off-target effects. Additionally, the presence of multiple aromatic rings and polar functional groups could reduce cell permeability and bioavailability, limiting its effectiveness as a JNK3 inhibitor in vivo.",
            "Optimization for Source Molecule": "Modify the amide linkage to a more rigid or bioisosteric group to enhance binding specificity. Introduce substituents that exploit unique binding pockets of JNK3 to improve selectivity. Reduce the number of polar functional groups or incorporate lipophilic moieties to enhance cell permeability and overall bioavailability.",
            "Final Target Molecule": "Nc1n[nH]c2cccc(-c3ccc(NC(=O)N(C)c4cccc(F)c4)cc3)c12"
        }
    },
    {
        "src_smiles": "CCN(CC)CCn1c(NC(=O)c2ccc(C)cc2)nc2ccccc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a morpholine ring connected to a benzamide moiety via a flexible alkyl linker. It contains multiple aromatic rings which may facilitate \u03c0-\u03c0 stacking interactions with the JNK3 kinase. The presence of nitrogen atoms in the linker could form hydrogen bonds, enhancing binding affinity.",
            "Property Analysis": "The molecule exhibits moderate inhibitory activity against JNK3. Its structural elements suggest potential for further optimization to enhance potency and selectivity. The basic amine groups may contribute to cellular permeability, while the aromatic rings provide a scaffold for interaction with the kinase domain.",
            "Limitation in Source Molecule for Property": "The current scaffold may lack sufficient hydrogen bonding donors or acceptors required for optimal interaction with key residues in the JNK3 active site. Additionally, the bulky aromatic rings might lead to increased off-target interactions, reducing selectivity.",
            "Optimization for Source Molecule": "Introduce electron-withdrawing groups to increase binding affinity through enhanced hydrogen bonding. Modify or reduce bulky aromatic substituents to decrease off-target effects and improve selectivity. Incorporate rigidifying elements to restrict conformational flexibility, ensuring optimal orientation for kinase binding. Enhance water solubility by adding polar functional groups without compromising membrane permeability.",
            "Final Target Molecule": "CCN(CC)CCn1c(NC(=O)c2ccc(F)cc2)nc2ccccc21"
        }
    },
    {
        "src_smiles": "CC(C)n1cnc2c(NCc3ccccc3)nc(I)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features an isopropyl group attached to a tricyclic core comprising fused pyrimidine and pyrazine rings. It includes a benzyl ether linkage connected to a terminal aromatic ring and an iodine substituent on the heterocyclic system, which may contribute to its lipophilicity and potential binding interactions.",
            "Property Analysis": "The molecule exhibits structural elements commonly associated with kinase inhibitors, such as aromatic rings for \u03c0-\u03c0 stacking and halogen bonds. The presence of nitrogen atoms in the heterocyclic core can form hydrogen bonds with amino acid residues in JNK3, potentially enhancing inhibitory activity.",
            "Limitation in Source Molecule for Property": "The iodine substituent, while potentially beneficial for binding affinity, may negatively impact the molecule's metabolic stability and solubility. Additionally, the flexible benzyl linker could reduce binding specificity, leading to off-target effects and decreased selectivity for JNK3.",
            "Optimization for Source Molecule": "Replace the iodine atom with a less lipophilic and more metabolically stable group, such as a fluorine atom, to improve solubility and reduce potential toxicity. Introduce a methyl or ethyl substituent on the benzyl linker to restrict its flexibility, thereby enhancing binding specificity and affinity for the JNK3 active site. Additionally, consider adding substituents that can form additional hydrogen bonds with JNK3 to increase potency.",
            "Final Target Molecule": "CC(C)n1cnc2c(NCc3ccccc3)nc(F)nc21"
        }
    },
    {
        "src_smiles": "COc1cc2ncnc(N(C)c3ccc(F)c(Cl)c3)c2cc1OC",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, COc1cc2ncnc(N(C)c3ccc(F)c(Cl)c3)c2cc1OC, features a methoxy-substituted aromatic system fused with a triazole ring. It contains electron-withdrawing fluorine and chlorine atoms on the phenyl rings, which may influence binding affinity and metabolic stability.",
            "Property Analysis": "The compound exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3) with moderate potency. The presence of multiple aromatic rings and substituents suggests potential for strong interactions with the JNK3 active site.",
            "Limitation in Source Molecule for Property": "The source molecule may suffer from suboptimal selectivity for JNK3 over other kinases due to the presence of multiple aromatic and heterocyclic components. Additionally, the electron-withdrawing groups could affect the molecule's pharmacokinetic properties, such as solubility and metabolic stability.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, structural modifications will focus on improving selectivity and potency. This includes replacing or modifying electron-withdrawing groups to optimize hydrogen bonding and hydrophobic interactions within the JNK3 active site. Reducing steric hindrance around the triazole ring may also improve binding affinity and selectivity.",
            "Final Target Molecule": "COc1cc2ncnc(N(C)c3ccc(F)c(Cl)c3)c2cc1OC"
        }
    },
    {
        "src_smiles": "COc1cc2c(Nc3ccc4c(c3)OCO4)ncnc2c(OC)c1OC",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule COc1cc2c(Nc3ccc4c(c3)OCO4)ncnc2c(OC)c1OC features a triazine core bonded to multiple methoxy groups and an acetal-linked aromatic system. This structure provides several sites for potential interactions, including hydrogen bonding and \u03c0-\u03c0 stacking, which are crucial for kinase inhibition.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3). The presence of methoxy groups may facilitate hydrogen bonding with amino acid residues in the JNK3 active site, while the triazine core provides a stable scaffold for binding. However, the current affinity and selectivity towards JNK3 may be suboptimal.",
            "Limitation in Source Molecule for Property": "The multiple methoxy groups may contribute to off-target interactions, reducing selectivity for JNK3. Additionally, the acetal linkage (OCO) could be prone to hydrolysis, potentially decreasing the molecule's stability and bioavailability. The planar aromatic system might also limit the molecule's conformational flexibility, hindering optimal binding interactions.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce substituents that increase hydrogen bonding specificity and lipophilicity to improve binding affinity and selectivity. Replace the acetal linkage with a more stable ether or amine linkage to enhance metabolic stability. Incorporate a heteroaryl group to provide additional points of interaction within the JNK3 active site, thereby improving selectivity and potency.",
            "Final Target Molecule": "COc1cc2c(Nc3ccc4c(c3)OCC4)nc(n2)c1OC"
        }
    },
    {
        "src_smiles": "Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N3CCC(O)C3)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a purine core with a ketone substituent and multiple fluorinated aromatic groups. It also contains a morpholine moiety linked through a methylene bridge, providing potential hydrogen bonding interactions.",
            "Property Analysis": "The molecule exhibits potential as a c-Jun N-terminal kinase 3 (JNK3) inhibitor due to its ability to form hydrogen bonds and engage in \u03c0-\u03c0 interactions within the JNK3 active site. The fluorinated aromatic rings may enhance binding affinity and metabolic stability.",
            "Limitation in Source Molecule for Property": "The presence of multiple fluorine atoms may limit the molecule's solubility and increase metabolic liabilities. Additionally, the morpholine moiety might reduce cell permeability, affecting the molecule's bioavailability.",
            "Optimization for Source Molecule": "Introduce polar but hydrogen bond-friendly substituents to improve solubility without compromising binding affinity. Replace the morpholine ring with a more lipophilic amine to enhance cell permeability. Modify the fluorinated aromatic rings to balance metabolic stability with electronic properties necessary for JNK3 binding.",
            "Final Target Molecule": "Cn1c(=O)c(Oc2ccc(CF3)cc2)cc2cnc(N3CCNC3)nc21"
        }
    },
    {
        "src_smiles": "C=CCn1c(SCC(=O)NCc2ccco2)nc2sc(C)c(C)c2c1=O",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule is a heterocyclic compound featuring a central pyridine ring substituted with a thiocarbamate group (SCC(=O)N) linked to a benzofuran moiety (Cc2ccco2). Additionally, it contains a dichloro-substituted thiazole ring attached to the pyridine nucleus. The molecule possesses both aromatic and aliphatic regions, which may contribute to its binding interactions with biological targets.",
            "Property Analysis": "The molecule exhibits potential as a JNK3 inhibitor due to its structural components that can engage in hydrogen bonding and hydrophobic interactions within the kinase's active site. The presence of the benzofuran moiety and the thiocarbamate linker may enhance specificity and binding affinity towards JNK3. Additionally, the dichloro substitutions can contribute to electronic modulation of the aromatic system, potentially improving interaction with the target protein.",
            "Limitation in Source Molecule for Property": "The current structure may face challenges related to selectivity and solubility. The dichloro substitutions, while beneficial for binding, might reduce solubility and increase off-target interactions. Furthermore, the thiocarbamate linker could be metabolically unstable, potentially leading to rapid degradation and reduced bioavailability. These factors may limit the overall efficacy and safety profile of the molecule as a JNK3 inhibitor.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibitory activity, the molecule can be optimized by introducing substituents that improve selectivity and metabolic stability. Replacing one of the chlorine atoms with a fluorine atom could maintain electronic benefits while enhancing metabolic stability. Additionally, modifying the thiocarbamate linker to a more stable amide or ester group could improve metabolic resistance. Incorporating a substituent on the benzofuran ring to increase hydrophobic interactions may further enhance binding affinity and selectivity towards JNK3.",
            "Final Target Molecule": "C=CCn1c(SCC(=O)NCc2c(C)cc(F)co2)nc2sc(C)c(C)c2c1=O"
        }
    },
    {
        "src_smiles": "COc1cc2ncnc(Nc3ccc(C(F)(F)F)cc3)c2c(OC)c1OC",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, COc1cc2ncnc(Nc3ccc(C(F)(F)F)cc3)c2c(OC)c1OC, features a fused bicyclic system with methoxy substituents. It contains a triazole ring linked to a trifluoromethyl-substituted aromatic amine, which may contribute to binding affinity through electronic and steric interactions. The presence of multiple methoxy groups enhances solubility and provides potential sites for hydrogen bonding.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), a key enzyme involved in inflammatory and apoptotic pathways. The trifluoromethyl group likely enhances binding affinity and selectivity towards JNK3 by interacting with hydrophobic pockets in the active site. The overall pharmacokinetic properties are favorable due to methoxy substitutions increasing solubility.",
            "Limitation in Source Molecule for Property": "While the source molecule shows promising JNK3 inhibition, the high lipophilicity from multiple methoxy groups may lead to poor bioavailability and off-target interactions. Additionally, the triazole core may lack sufficient specificity, potentially affecting selectivity against other kinases.",
            "Optimization for Source Molecule": "Modify the methoxy groups to reduce lipophilicity by introducing polar or hydrogen bond-forming substituents. Enhance specificity by adding substituents that can form additional hydrogen bonds or ionic interactions with unique residues in the JNK3 active site. Consider bioisosteric replacements for the trifluoromethyl group to improve binding interactions and selectivity.",
            "Final Target Molecule": "COc1cc2ncnc(Nc3ccc(C(F)(F)Cl)cc3)c2c(OC)c1OC"
        }
    },
    {
        "src_smiles": "OC1CCC(Nc2nc(NCCc3ccccc3)ncc2-c2ccccn2)CC1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a cyclohexanol core substituted with a pyrimidine-pyridine fused aromatic system. The pyrimidine ring is further functionalized with a benzylamine side chain, providing potential sites for hydrogen bonding and hydrophobic interactions.",
            "Property Analysis": "The molecule exhibits potential JNK3 inhibitory activity through interactions of the aromatic rings with the kinase's active site. The benzylamine moiety may form hydrogen bonds with key residues, enhancing binding affinity.",
            "Limitation in Source Molecule for Property": "The presence of the hydroxyl group may reduce cell permeability and metabolic stability. Additionally, the current substitution pattern may lead to suboptimal interactions with the JNK3 active site, limiting inhibitory potency and selectivity.",
            "Optimization for Source Molecule": "Introduce a methyl group on the pyridine ring to enhance hydrophobic interactions and increase selectivity for JNK3. Replace the hydroxyl group with a methoxy group to improve metabolic stability and cell permeability. Modify the benzylamine side chain by adding a fluoro-substituent to strengthen hydrogen bonding and enhance binding affinity.",
            "Final Target Molecule": "OC1CCCOC(C1)C2=CC(=NC(NCCc3ccccc3)N2)c2cccc(F)c2"
        }
    },
    {
        "src_smiles": "CCOc1ccc(CC(=O)Nc2c(C(N)=O)oc3ccc(Br)cc23)cc1OCC",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a diethyl ether linkage attached to a benzene ring. Substituted on this benzene is an amide bond connecting to a fused ring system comprising a furan and a brominated benzene. Key functional groups include ether, amide, furan, and bromine atoms, which may interact with the JNK3 active site through hydrogen bonding and hydrophobic interactions.",
            "Property Analysis": "The molecule demonstrates initial inhibitory activity against JNK3, likely due to its ability to fit into the kinase's ATP-binding pocket. The presence of the brominated ring may contribute to hydrophobic interactions essential for binding affinity.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from suboptimal selectivity and potency towards JNK3. The bromine atom, while contributing to hydrophobic interactions, could limit selectivity by interacting with other kinases. Additionally, the molecule may have issues with metabolic stability and cell permeability due to its size and functional groups.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce electron-withdrawing groups to increase binding affinity and selectivity. Replace the bromine atom with a more selective substituent to reduce off-target effects. Modify the ether linkage to improve metabolic stability and incorporate a heterocyclic moiety to better occupy the JNK3 binding pocket.",
            "Final Target Molecule": "CCOc1ccc(CC(=O)Nc2c(C(N)=O)Oc3nccc(Cl)cc3c2)cc1OCC"
        }
    },
    {
        "src_smiles": "CN(C)Cc1ccn2c(-c3ccnc(S(C)(=O)=O)n3)c(-c3ccc(F)cc3)nc2c1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a central pyrazine ring linked to a dimethylaminoethyl side chain. It is substituted with a triazole-based sulfonamide group and a fluorophenyl moiety, providing multiple interaction points for binding to JNK3 through hydrogen bonding and hydrophobic interactions.",
            "Property Analysis": "The molecule demonstrates moderate JNK3 inhibitory activity, benefiting from hydrogen bonding via the sulfonamide group and hydrophobic interactions from the fluorophenyl group. However, the interaction strength and selectivity may be suboptimal for high-potency inhibition.",
            "Limitation in Source Molecule for Property": "The current substituents may not fully exploit all binding pockets within JNK3's active site, limiting binding affinity and selectivity. Additionally, the presence of a single fluorine atom may not provide sufficient hydrophobic interactions required for stronger inhibition.",
            "Optimization for Source Molecule": "Enhance hydrophobic interactions by introducing additional fluorine atoms to the phenyl ring, thereby increasing binding affinity and selectivity towards JNK3. Alternatively, modify the triazole sulfonamide group to incorporate bulkier substituents that can better occupy hydrophobic pockets or form more hydrogen bonds within the active site. Rigidifying the molecular structure could also improve binding specificity.",
            "Final Target Molecule": "CN(C)Cc1ccn2c(-c3ccnc(S(C)(=O)=O)n3)c(-c3c(F)cc(F)c3)nc2c1."
        }
    },
    {
        "src_smiles": "COCCn1c(=O)c(-c2ccc(OC)cc2)nc2cnc(OCc3ccccc3)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a 1,2,4-triazole core with multiple substituents. It has two methoxy (OC) groups attached to aromatic rings and an ethoxy (COC) linker. The molecule features a fused ring system incorporating nitrogen atoms, which may contribute to its binding affinity through hydrogen bonding interactions.",
            "Property Analysis": "The molecule is designed to inhibit c-Jun N-terminal kinase 3 (JNK3). The presence of methoxy groups enhances lipophilicity, potentially improving membrane permeability. The triazole ring offers rigidity and planar conformation, which can enhance binding specificity and affinity towards the JNK3 active site.",
            "Limitation in Source Molecule for Property": "The current structure may exhibit limited selectivity towards JNK3 over other kinases due to similar binding pockets. Additionally, the molecule's metabolic stability might be affected by the ethoxy linker, which could be prone to oxidative metabolism, reducing its effective concentration in vivo.",
            "Optimization for Source Molecule": "Introduce electron-withdrawing groups to increase binding affinity and selectivity towards JNK3. Replace the ethoxy linker with a more metabolically stable moiety, such as a fluorinated group, to enhance metabolic stability. Modify the substituents on the aromatic rings to optimize interactions within the JNK3 binding pocket, potentially increasing specificity.",
            "Final Target Molecule": "COCFn1c(=O)c(-c2ccc(OF)cc2)nc2cnc(OCc3ccccc3)nc21"
        }
    },
    {
        "src_smiles": "Cc1ncc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)s1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a methyl-substituted pyridine ring connected via an amide linkage to a substituted benzene ring. The benzene ring is further substituted with a dimethylamino group and a complex fused ring system containing a pyrimidine core with a nitro functional group. Key functional groups include methyl, amide, dimethylamino, pyrimidine, and nitro groups, contributing to the molecule's overall aromatic character and potential for hydrogen bonding.",
            "Property Analysis": "The source molecule exhibits inhibitory activity against JNK3 (c-Jun N-terminal kinase 3), likely through interactions with the ATP-binding site of the kinase. The presence of multiple aromatic rings and polar functional groups may facilitate strong binding affinity and specificity. However, the molecule's complex structure might influence its pharmacokinetic properties, such as solubility and membrane permeability.",
            "Limitation in Source Molecule for Property": "The source molecule may suffer from limited selectivity, potentially interacting with other kinases due to its extensive aromatic framework and multiple hydrogen bond donors/acceptors. Additionally, the molecule's high molecular weight and lipophilicity could adversely affect its bioavailability and metabolic stability, leading to suboptimal therapeutic profiles.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, the molecule can be streamlined by reducing unnecessary aromatic rings to improve selectivity and pharmacokinetic properties. Introducing substituents that specifically interact with unique residues in the JNK3 binding pocket can increase affinity. Replacing or modifying the nitro group with bioisosteres could enhance metabolic stability and reduce potential toxicity. Optimizing the balance between hydrophilic and lipophilic regions will improve solubility and membrane permeability.",
            "Final Target Molecule": "Cc1ncc(C(=O)Nc2ccc(CCNC3ncnc4c(C(N)=O)cccc34)c2)s1"
        }
    },
    {
        "src_smiles": "NC1=NC(CF)(c2cc(Oc3ncccc3F)ccc2F)CC(C(F)(F)F)O1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a pyrimidine core substituted with a trifluoromethyl group, a fluorinated phenyl ether linked to a fluorinated pyridine moiety, and a tertiary alcohol with a CF\u2083 group. These substituents contribute to enhanced lipophilicity, metabolic stability, and potential hydrogen bonding interactions crucial for JNK3 inhibition.",
            "Property Analysis": "The compound demonstrates moderate to high JNK3 inhibitory activity, likely due to optimal interactions within the JNK3 active site. The electron-withdrawing trifluoromethyl groups increase binding affinity and improve metabolic resilience. The presence of multiple fluorine atoms may enhance selectivity and binding specificity towards JNK3.",
            "Limitation in Source Molecule for Property": "Despite its favorable properties, the molecule may exhibit suboptimal selectivity against other kinases due to its highly lipophilic nature. The tertiary alcohol could be susceptible to metabolic degradation, potentially reducing the compound's bioavailability and effectiveness. Additionally, the bulky trifluoromethyl groups might hinder binding flexibility.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, modify the trifluoromethyl groups to smaller or alternative electron-withdrawing substituents to enhance selectivity. Replace the tertiary alcohol with a more metabolically stable ether or amine linkage to increase bioavailability. Introduce additional hydrogen bond donors or acceptors to strengthen specific interactions with JNK3's active site. Reduce overall lipophilicity to minimize off-target effects and improve selectivity.",
            "Final Target Molecule": "NC1=NC(CF)(c2cc(Oc3ncccc3F)ccc2F)CC(CF\u2083)O1"
        }
    },
    {
        "src_smiles": "COCCNC1CCC(Nc2cc(-c3nc(NCC4CCOCC4)ccc3Cl)c(Cl)cn2)CC1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features an ether linkage (COCCN) connected to a piperidine ring (C1CCC(CC1)). It contains multiple aromatic rings with chloro substituents and a morpholine moiety (NCC4CCOCC4). The molecule includes hydrogen bond donors and acceptors, which may facilitate interactions with the JNK3 kinase active site.",
            "Property Analysis": "The molecule serves as an inhibitor of c-Jun N-terminal kinase 3 (JNK3), potentially modulating its role in cellular signaling pathways. Its current inhibitory potency suggests moderate efficacy, with potential for enhanced selectivity and binding affinity through structural optimization.",
            "Limitation in Source Molecule for Property": "Potential limitations include suboptimal selectivity against other kinases due to the presence of multiple polar groups, which may affect cell permeability and lead to off-target effects. The ether linkage and morpholine moiety could also be sites of metabolic instability, reducing the molecule's overall efficacy and half-life.",
            "Optimization for Source Molecule": "Introduce modifications to enhance selectivity and binding affinity for JNK3 by targeting unique residues in the kinase's active site. Replace the ether linkage with a more metabolically stable amide or carbamate group to improve stability. Reduce polarity by substituting some polar groups with lipophilic moieties to enhance cell permeability. Optimize the aromatic regions by adding or modifying substituents to strengthen \u03c0-\u03c0 stacking interactions with JNK3.",
            "Final Target Molecule": "CONCNC1CCC(Nc2cc(-c3nc(NCC4CCOCC4)ccc3Cl)c(Cl)cn2)CC1"
        }
    },
    {
        "src_smiles": "CC(C)n1cnc2c(NCc3ccc(-c4ccccc4)cc3)nc(N(CCO)CCO)nc21",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule contains a central pyrimidine core fused with a triazole ring, featuring multiple substituents. It has a sec-butyl group attached to the triazole nitrogen, a morpholine-linked amide with diethylene glycol chains, and a phenyl ring substituted with a biphenyl moiety.",
            "Property Analysis": "The compound exhibits moderate inhibition of c-Jun N-terminal kinase 3 (JNK3), a kinase involved in various cellular processes. The molecule interacts with the ATP-binding site of JNK3, likely through hydrogen bonding and hydrophobic interactions provided by its aromatic rings and substituents.",
            "Limitation in Source Molecule for Property": "The current molecule may suffer from suboptimal binding affinity and selectivity towards JNK3 due to limited hydrophobic interactions and possible steric hindrance from bulky substituents. Additionally, the presence of diethylene glycol chains may negatively impact the molecule's cell permeability and metabolic stability.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, introduce bulkier and more rigid substituents to improve binding affinity and selectivity. Replace the diethylene glycol chains with more metabolically stable linkers, and modify the biphenyl moiety to enhance hydrophobic interactions within the JNK3 binding pocket. Additionally, streamline the molecule to reduce steric hindrance and improve overall drug-likeness.",
            "Final Target Molecule": "CC(C)n1cnc2c(NC(C3=CC=CC=C3)c4ccccc4)nc(N(C[C@H](CO)CO)NC)c21"
        }
    },
    {
        "src_smiles": "COc1cc2ncnc(Nc3cc(Cl)ccc3Cl)c2cc1OCCCCCC(=O)NO",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a methoxy-substituted aromatic core fused with a triazole ring, adorned with two para-chlorophenyl groups. It includes a hexanoyl linker connected to a nitro group, which may contribute to its biological activity.",
            "Property Analysis": "The molecule exhibits potential inhibition of JNK3 due to the presence of electron-withdrawing chlorine and nitro groups, which can enhance binding interactions through hydrogen bonding and \u03c0-\u03c0 stacking within the kinase active site.",
            "Limitation in Source Molecule for Property": "The multiple electron-withdrawing groups may reduce the molecule's lipophilicity, potentially hindering cell permeability. Additionally, the nitro group poses metabolic instability and potential toxicity concerns, which can limit the compound's drug-likeness.",
            "Optimization for Source Molecule": "Replace the metabolically unstable nitro group with a more stable bioisostere such as a trifluoromethyl group to enhance metabolic stability and reduce toxicity. Adjust the linker length to optimize binding affinity and improve cell permeability by achieving a balance in lipophilicity. Consider reducing the number of chlorine substituents to enhance drug-like properties while maintaining essential binding interactions.",
            "Final Target Molecule": "COc1cc2ncnc(Nc3cc(Cl)ccc3Cl)c2cc1OCCCCCC(=O)CF3"
        }
    },
    {
        "src_smiles": "CS(=O)(=O)Nc1ccc(-c2cnc3cccc(Nc4ncccc4Cl)c3c2)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule features a sulfonamide linkage (CS(=O)(=O)N) connecting an aromatic aniline moiety to a complex fused heterocyclic system. The structure includes a chloro-substituted nitrogen-containing bicyclic framework, which may facilitate interactions with the JNK3 active site through hydrogen bonding and hydrophobic interactions.",
            "Property Analysis": "The molecule acts as a c-Jun N-terminal kinase 3 (JNK3) inhibitor. The sulfonamide group likely forms key hydrogen bonds within the kinase's hinge region, while the chloro substituent enhances binding affinity through hydrophobic interactions. The fused heterocyclic system may contribute to the molecule's selectivity and potency against JNK3.",
            "Limitation in Source Molecule for Property": "Potential limitations include suboptimal selectivity, as the scaffold might interact with other kinases sharing similar ATP-binding sites. Additionally, the molecule may suffer from poor solubility or metabolic instability, which can affect its bioavailability and overall therapeutic efficacy.",
            "Optimization for Source Molecule": "Enhancements could involve introducing substituents that exploit unique pockets in the JNK3 active site to improve selectivity. Modifying the sulfonamide linker to enhance hydrogen bonding interactions and adding polar groups could improve solubility and metabolic stability. Altering the fused heterocyclic core to reduce off-target kinase interactions while maintaining or increasing binding affinity to JNK3 is also recommended.",
            "Final Target Molecule": "CS(=O)(=O)Nc1ccc(-c2cnc3ccc(CCN(C)C)c(Cl)c3c2)cc1)O"
        }
    },
    {
        "src_smiles": "COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCC(=O)NO",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxy-substituted phenyl ring connected to a pyrimidine core, which is further linked to a bromophenyl group and a sulfonamide moiety. The presence of methoxy and bromo substituents may influence electronic distribution and binding interactions with the target enzyme.",
            "Property Analysis": "The molecule functions as an inhibitor of c-Jun N-terminal kinase 3 (JNK3), a protein kinase involved in regulating various cellular processes including inflammation and apoptosis. Effective inhibition of JNK3 can have therapeutic implications in diseases such as neurodegeneration and cancer.",
            "Limitation in Source Molecule for Property": "The current structure may exhibit suboptimal selectivity towards JNK3 over other kinases, potentially leading to off-target effects. Additionally, the molecule might possess limited metabolic stability or bioavailability, affecting its overall efficacy as a therapeutic agent.",
            "Optimization for Source Molecule": "Enhancements can be made by introducing electron-withdrawing groups to increase binding affinity with JNK3's active site or by adding substituents that improve selectivity. Modifying the sulfonamide linker to a more metabolically stable moiety could also enhance pharmacokinetic properties. For instance, replacing the bromine with a fluorine atom may improve metabolic stability and binding interactions.",
            "Final Target Molecule": "COc1cc2ncnc(Nc3cccc(F)c3)c2cc1OCCC(=O)NO"
        }
    },
    {
        "src_smiles": "CC(=O)NC(C)c1ccc(OC2CCN(c3ccnc(N4CCCC(F)(F)C4)n3)C2)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an acetamide moiety attached to a substituted benzene ring. The benzene ring is further linked through a methoxy group to a piperazine ring, which is connected to a triazole-fused piperidine ring with difluoro substitutions.",
            "Property Analysis": "The molecule is designed to inhibit JNK3 by interacting with its ATP-binding site, utilizing hydrogen bonding from the amide and triazole groups, and hydrophobic interactions from the aromatic rings and difluoro-substituted piperidine.",
            "Limitation in Source Molecule for Property": "Potential limitations include suboptimal selectivity towards JNK3 over other kinases, limited aqueous solubility due to extensive hydrophobic regions, and possible metabolic instability caused by the methoxy and piperidine moieties.",
            "Optimization for Source Molecule": "Introduce polar substituents to enhance solubility, modify the aromatic rings to improve selectivity by introducing substituents that engage in specific interactions with JNK3, and replace the methoxy group with a more metabolically stable linker. Additionally, exploring alternative heterocycles in place of the piperidine ring could enhance specificity and reduce off-target effects.",
            "Final Target Molecule": "CC(=O)NC(C)c1cc(CO)ccc1OC2CCN(c3ccnc(N4CCCC(F)(F)C4)n3)C2)C5=NC=CC=C5"
        }
    },
    {
        "src_smiles": "CC(C)C(CO)Nc1nc(NCc2cccc(I)c2)c2ncn(C(C)C)c2n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central aliphatic amine connected to a pyrimidine core. It features a secondary alcohol group for potential hydrogen bonding and a para-iodophenyl substituent which may interact hydrophobically within the JNK3 active site. The molecule also contains isopropyl groups that contribute to its lipophilicity.",
            "Property Analysis": "The molecule demonstrates moderate inhibition of JNK3 with potential for improved selectivity and binding affinity. The iodophenyl group likely engages in hydrophobic interactions, while the secondary alcohol may form hydrogen bonds with the kinase. However, the overall binding affinity could be enhanced through structural modifications.",
            "Limitation in Source Molecule for Property": "The presence of the bulky iodine atom may hinder optimal binding and reduce selectivity due to steric clashes. Additionally, the secondary alcohol might limit the molecule\u2019s metabolic stability and pharmacokinetic properties. The current substituents may not fully exploit key interactions within the JNK3 active site.",
            "Optimization for Source Molecule": "Replace the bulky iodine atom with a smaller, electron-withdrawing group such as a trifluoromethyl to enhance binding affinity and selectivity. Modify the secondary alcohol to a more stable ether or amine to improve metabolic stability. Introduce a methyl group on the pyrimidine ring to optimize interactions with the JNK3 binding pocket.",
            "Final Target Molecule": "CC(C)C(CO)Nc1nc(NCc2ccc(C(F)(F)F)c2)c2ncn(C(C)C)c2n1"
        }
    },
    {
        "src_smiles": "COc1ccc(C=CC(=O)Nc2cc(-c3c(-c4ccc(F)cc4)nc(SC)n3C)ccn2)cc1",
        "prop": "jnk",
        "json_results": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule comprises a methoxy-substituted phenyl ring connected to a cinnamide core. This core is further linked to a triazine-containing aromatic system, which is substituted with a fluorophenyl group and a thiocarbamate moiety. The molecule features multiple aromatic rings, amide linkages, and electron-withdrawing groups that contribute to its overall structure.\",\n    \"Property Analysis\": \"The molecule exhibits potential JNK3 inhibitory activity attributed to its amide bond and aromatic substituents, which can engage in hydrogen bonding and hydrophobic interactions within the JNK3 active site. The presence of electron-withdrawing groups like fluorine may enhance binding affinity and metabolic stability. However, the overall activity is contingent on the precise arrangement and electronic properties of these functional groups.\",\n    \"Limitation in Source Molecule for Property\": \"The current structure may have limited selectivity towards JNK3 due to the presence of multiple aromatic rings that could interact with off-target kinases. Additionally, the amide linkage might be susceptible to metabolic hydrolysis, potentially reducing the molecule's stability and bioavailability. The lack of specific functional groups necessary for optimal interaction with key JNK3 residues may also impede binding affinity.\",\n    \"Optimization for Source Molecule\": \"To enhance JNK3 inhibition, introduce a urea linkage in place of the amide to increase metabolic stability and hydrogen bonding potential. Incorporate a pyridine ring to improve selectivity by facilitating specific interactions with JNK3's active site. Additionally, adding a methyl group ortho to the methoxy group on the phenyl ring could enhance binding affinity through hydrophobic interactions. Substituting the thiocarbamate with a more rigid sulfonyl group may also improve binding specificity and overall inhibitory potency.\",\n    \"Final Target Molecule\": \"COc1ccc(C=C(C(=O)N(C)C2=NC=C(C=C2)C3=NC=C(C=C3F)N=C(N)S(=O)C)cc1)cc1)C\n}"
    },
    {
        "src_smiles": "COC1CCCN(c2nccc(N3CCC(Oc4ccc(C(C)NC(C)=O)cc4)C3)n2)C1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a cyclohexylamine core (COC1CCCN) connected to a fused bicyclic system. It features a triazole ring (n2nccc) linked to a piperidine ring (N3CCC) bearing an ether linkage (Oc4ccc) connected to a phenyl ring substituted with an acetamide group (C(C)NC(C)=O). The molecule contains multiple nitrogen heterocycles, ether functionalities, and an amide moiety which are critical for its biological activity.",
            "Property Analysis": "The source molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), which plays a role in various cellular processes including inflammation and apoptosis. The presence of multiple nitrogen atoms and the amide group may facilitate binding interactions with the JNK3 active site, enhancing its inhibitory potency.",
            "Limitation in Source Molecule for Property": "Despite its activity, the source molecule may suffer from limited selectivity towards JNK3 over other kinases, potential metabolic instability due to the ether linkage, and suboptimal pharmacokinetic properties such as poor solubility or bioavailability. Additionally, the bulky cyclohexyl group might hinder optimal binding affinity and specificity.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, modifications can be made to enhance selectivity and binding affinity while addressing metabolic stability. Replacing the cyclohexyl group with a more rigid and planar aromatic system could improve interactions within the ATP-binding pocket of JNK3. Introducing electron-withdrawing groups on the phenyl rings may increase binding affinity. Modifying the ether linkage to a more metabolically stable linkage, such as a thioether, could enhance metabolic stability. Additionally, optimizing the amide substituents to better fit the active site may improve selectivity.",
            "Final Target Molecule": "COC1CCCN(c2nccc(N3CCC(Sc4ccc(C(C)NC(C)=O)cc4)C3)n2)C1)"
        }
    },
    {
        "src_smiles": "COc1cc2ncnc(N3CCN(C(=O)NCc4ccc(Br)cc4)CC3)c2cc1OC",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxy-substituted phenyl ring fused with a bicyclic pyrimidine structure. It incorporates a triazacyclononane backbone connected to a benzamide moiety bearing a bromine substituent, which may facilitate hydrogen bonding and hydrophobic interactions with the JNK3 enzyme.",
            "Property Analysis": "The molecule demonstrates moderate inhibition of JNK3 kinase with potential interactions at the ATP-binding site. The presence of the benzamide group and bromine substituent contributes to its binding affinity and specificity towards JNK3.",
            "Limitation in Source Molecule for Property": "The compound exhibits limited selectivity for JNK3 over other kinases, which may lead to off-target effects. Additionally, the bromine substituent could pose metabolic liabilities and reduce the molecule's overall drug-like properties.",
            "Optimization for Source Molecule": "Enhance selectivity and binding affinity by replacing the bromine atom with a less metabolically susceptible substituent, such as a fluorine or methyl group. Introduce electron-donating groups to the benzamide ring to strengthen hydrogen bonding with JNK3. Modify the triazacyclononane core to improve conformational rigidity and optimize interactions within the JNK3 active site.",
            "Final Target Molecule": "COc1cc2ncnc(N3CCN(C(=O)NCc4ccc(F)cc4)CC3)c2cc1OC"
        }
    },
    {
        "src_smiles": "COc1ccc(NC(=O)Nc2ccc(N(C)c3ncnc4cc(OC)c(OC)cc34)cc2)cc1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a central benzene ring substituted with a methoxy group (\u2013OCH\u2083) and an amide-linked aromatic side chain. The side chain features a pyridine ring fused with a triazole moiety, further substituted with additional methoxy groups. The molecule incorporates multiple aromatic rings, methoxy substituents, amide bonds, and nitrogen-containing heterocycles, contributing to its planar structure and potential for hydrogen bonding.",
            "Property Analysis": "The source molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3) by interacting with the ATP-binding site of the enzyme. The presence of hydrogen bond donors and acceptors, along with the extended aromatic system, facilitates strong binding affinity and specificity towards JNK3, potentially disrupting its kinase activity and downstream signaling pathways.",
            "Limitation in Source Molecule for Property": "The source molecule may have limited selectivity for JNK3 over other kinases due to the conserved nature of ATP-binding sites. Additionally, the high lipophilicity from multiple methoxy groups could result in poor bioavailability and increased risk of off-target interactions. The rigid fused ring system might also restrict the necessary conformational flexibility required for optimal binding interactions with JNK3.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, the molecule can be optimized by introducing substituents that increase selectivity, such as adding halogen atoms (e.g., fluorine or chlorine) to engage unique amino acid residues in the JNK3 binding pocket. Reducing lipophilicity by replacing some methoxy groups with more polar functional groups like hydroxyl or amino groups could improve bioavailability. Additionally, incorporating a flexible linker or modifying the fused ring system to allow greater conformational adaptability may enhance binding interactions and metabolic stability.",
            "Final Target Molecule": "COc1ccc(NC(=O)Nc2ccc(N(C)c3ncnc4cc(F)c(OH)cc34)cc2)cc1"
        }
    },
    {
        "src_smiles": "CSc1nc(N)cc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule, CSc1nc(N)cc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1, features a thioether-linked pyrimidine core substituted with a fluorinated phenyl group and a piperazine-containing moiety. The presence of the fluorine atom enhances lipophilicity and metabolic stability, while the piperazine ring may contribute to binding interactions with the JNK3 kinase active site.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3), potentially through interactions with key residues in the ATP-binding pocket. The fluorinated phenyl group may engage in hydrophobic and halogen bonding interactions, while the piperazine moiety could form hydrogen bonds or ionic interactions, contributing to the compound's potency and selectivity.",
            "Limitation in Source Molecule for Property": "The current structure may suffer from suboptimal selectivity towards JNK3 over other kinases due to the flexible piperazine linkage, which can adopt multiple conformations, potentially reducing binding specificity. Additionally, metabolic stability might be limited by the thioether linkage, which is susceptible to oxidation.",
            "Optimization for Source Molecule": "To enhance JNK3 inhibition, the thioether linkage can be replaced with a more metabolically stable amide or ether bond to improve pharmacokinetic properties. Introducing rigidity into the molecule by cyclizing the piperazine ring could increase binding specificity and selectivity. Modifying the fluorinated phenyl group to include additional substituents may strengthen hydrophobic interactions and halogen bonding with the kinase active site.",
            "Final Target Molecule": "CCNc1nc(N)cc(-c2c(c3ccc(F)cc3)ncn2NCCOCCN2CCOCC2)n1"
        }
    },
    {
        "src_smiles": "CCOC(=O)Nc1ncc(Oc2cc(I)c(OC)cc2C(C)C)c(N)n1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of an ethoxy amide linked to a substituted pyrimidine ring. The pyrimidine ring is further substituted with an ether moiety containing an iodine atom, methoxy groups, and a tert-butyl group. These substituents may facilitate interactions with the JNK3 binding site through hydrophobic and hydrogen bonding interactions.",
            "Property Analysis": "The molecule is designed to inhibit JNK3 by forming key interactions within the kinase's active site. The presence of the iodine atom and tert-butyl group may enhance binding affinity through hydrophobic interactions, while the amide linkage and pyrimidine core can participate in hydrogen bonding with the kinase's active site residues. The overall lipophilicity may contribute to cellular permeability.",
            "Limitation in Source Molecule for Property": "The tert-butyl group may introduce steric hindrance, potentially reducing binding affinity and selectivity towards JNK3. Additionally, the iodine atom could lead to metabolic instability and off-target effects, limiting the molecule's drug-like properties and safety profile.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, the steric bulk of the tert-butyl group can be reduced by substituting it with a less bulky alkyl group, such as a methyl or ethyl group, to enhance binding affinity and selectivity. Replacing the iodine atom with a fluorine atom can improve metabolic stability and reduce off-target interactions while maintaining favorable binding characteristics. Additionally, introducing additional hydrogen bond donors or acceptors could strengthen interactions with the kinase's active site.",
            "Final Target Molecule": "CCOC(=O)Nc1ncc(Oc2cc(F)c(OC)cc2C)c(N)n1"
        }
    },
    {
        "src_smiles": "CCCONC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule comprises a propyl chain linked to a carbonyl group, which is attached to a phenyl ring. This phenyl ring is connected via a sulfur atom to a fused ring system containing a thiophene moiety substituted with a pyridine ring. The structure features nitrogen-containing heterocycles that may participate in hydrogen bonding interactions.",
            "Property Analysis": "The molecule exhibits inhibitory activity against c-Jun N-terminal kinase 3 (JNK3). The presence of the pyridine ring likely facilitates binding to the ATP-binding site of JNK3 through hydrogen bonding. The hydrophobic regions of the molecule contribute to van der Waals interactions, enhancing binding affinity.",
            "Limitation in Source Molecule for Property": "The current structure may lack optimal selectivity for JNK3 over other kinases due to the presence of common pharmacophoric elements. Additionally, the molecule's overall polarity could negatively impact its cell permeability and bioavailability. The flexibility of the propyl chain might reduce binding specificity.",
            "Optimization for Source Molecule": "Introduce substituents that increase selectivity for JNK3 by targeting unique binding pocket features. Replace the flexible propyl chain with a more rigid linker to enhance binding specificity. Add lipophilic groups to improve cell permeability and optimize pharmacokinetic properties. Modify the thiophene-pyridine system to enhance hydrogen bonding interactions within the JNK3 active site.",
            "Final Target Molecule": "CC(C)C(=O)c1ccccc1Sc1cccc2c(C=Cc3ccccn3)n[nH]c2c1"
        }
    },
    {
        "src_smiles": "CCOC(=O)CN1C(=O)SC(=Cc2ccc(-c3ccc(Cl)cc3Cl)o2)C1=O",
        "prop": "jnk",
        "json_results": {
            "Structural Analysis of Source Molecule": "The source molecule consists of a methoxy group connected to an amide linkage, a thioacyl moiety, and a substituted benzene ring with two chlorine atoms. The structure includes a fused heterocyclic system with potential hydrogen bond donors and acceptors, as well as lipophilic regions that may interact with the JNK3 active site.",
            "Property Analysis": "The molecule exhibits potential as a JNK3 inhibitor due to the presence of functional groups capable of forming key interactions within the kinase binding pocket. The methoxy and amide groups may serve as hydrogen bond donors/acceptors, while the chlorine-substituted aromatic rings contribute to hydrophobic interactions essential for binding affinity and selectivity.",
            "Limitation in Source Molecule for Property": "The presence of multiple chlorine atoms may lead to reduced selectivity and potential off-target effects. Additionally, the thioacyl group could introduce metabolic liabilities, affecting the molecule's stability and bioavailability. The current substitution pattern may not optimally engage all critical binding interactions required for enhanced JNK3 inhibition.",
            "Optimization for Source Molecule": "To improve JNK3 inhibition, remove or replace the chlorine substituents with more electron-donating groups to enhance binding affinity. Replace the thioacyl group with a more metabolically stable amide linkage. Introduce additional hydrogen bond acceptors or donors to form stronger interactions within the JNK3 active site. Optimize the aromatic substitution to increase selectivity and reduce potential off-target interactions.",
            "Final Target Molecule": "CCOC(=O)CN1C(=O)NC(=Cc2ccc(-c3ccncc3)o2)C1=O"
        }
    }
]